Clinical Trials Search

Find upcoming clinical trial events for your portfolio.

NCT IDTitleStatusPrimary Completion DatePhasesCompaniesStart DateCompletion Date
NCT07049328HCW9302 (Interleukin-2 Fusion Protein) for Alopecia AreataRECRUITING2026-07-16PHASE12025-08-162026-12-15
NCT05583227Efficacy and Safety of Tezepelumab in Patients With Eosinophilic EsophagitisACTIVE_NOT_RECRUITING2026-07-16PHASE32022-11-102027-03-25
NCT06539481Open Label Trial Studying the Safety and Effectiveness of ILUVIEN® (190μg) in Children and Adolescents, Who Have Recurrent Non-infectious Uveitis Affecting the Posterior Segment of the Eye.RECRUITING2026-07-15PHASE42024-08-312028-10-31
NCT06748053A Dose Finding Study With an Anti-TSLP Antibody (GSK5784283) in Adults Aged 18 to 75 Years of Age With Uncontrolled AsthmaRECRUITING2026-07-15PHASE22025-02-102027-01-14
NCT06387342Namodenoson Treatment of Advanced Pancreatic CancerRECRUITING2026-07-15PHASE22024-11-102026-12-15
NCT06317311A Study of Dostarlimab in Combination With Carboplatin-paclitaxel in Japanese Participants With Primary Advanced or Recurrent Endometrial CancerACTIVE_NOT_RECRUITING2026-07-15PHASE22024-05-072027-08-31
NCT06881251A Study of JNJ-95475939 in the Treatment of Participants With Moderate to Severe Atopic Dermatitis (AD)RECRUITING2026-07-15PHASE22025-02-262026-08-14
NCT06548100A Study of the Safety of Mibavademab in Pediatric and Adult Participants Switching From Metreleptin to Mibavademab for the Treatment of Generalized Lipodystrophy (GLD)ACTIVE_NOT_RECRUITING2026-07-14PHASE32024-12-162026-11-03
NCT06188507A First Time in Human Study to Evaluate the Safety and Tolerability of GSK3996401 Following Dosing With GSK4347859 in Healthy ParticipantsSUSPENDED2026-07-14PHASE12024-01-122026-07-14
NCT06832618A Study to Assess the Efficacy and Safety of Ruxolitinib Cream in Children and Adolescents (6 to <18 Years Old) With Moderate Atopic DermatitisRECRUITING2026-07-13PHASE32025-06-172028-05-18
NCT05630352A Study to Learn About Bivalent COVID-19 RNA Vaccine Candidate(s) in Healthy Infants and ChildrenWITHDRAWN2026-07-13PHASE12025-01-062026-07-13
NCT05039840Efficacy and Safety of Frexalimab (SAR441344) in the Treatment of Systemic Lupus ErythematosusRECRUITING2026-07-10PHASE22021-11-102026-10-02
NCT06112743A Study to Evaluate Mavacamten Impact on Myocardial Structure in Participants With Symptomatic Obstructive Hypertrophic CardiomyopathyACTIVE_NOT_RECRUITING2026-07-09PHASE42024-01-242026-07-09
NCT06851858Efficacy, Safety and Tolerability of AZD6234 in Participants Living With Overweight or Obesity With Type 2 Diabetes Who Are on a Stable Dose of GLP-1 Receptor AgonistRECRUITING2026-07-08PHASE22025-03-122026-07-08
NCT06194448To Evaluate the Efficacy/Safety of Osimertinib Prior to CRT and Maintenance of it With Stage III, Unresectable NSCLC With EGFR MutationsACTIVE_NOT_RECRUITING2026-07-07PHASE22024-04-212027-07-07
NCT04380636Study of Pembrolizumab With Concurrent Chemoradiation Therapy Followed by Pembrolizumab With or Without Olaparib in Stage III Non-Small Cell Lung Cancer (NSCLC) (MK-7339-012/KEYLYNK-012)ACTIVE_NOT_RECRUITING2026-07-06PHASE32020-07-062027-02-15
NCT06088199A Study of Apremilast in Pediatric Participants in Children With Mild to Moderate Plaque PsoriasisRECRUITING2026-07-06PHASE32023-10-242026-07-06
NCT06864169A Study of Raludotatug Deruxtecan (R-DXd) in People With Gastrointestinal Cancers (MK-5909-005)RECRUITING2026-07-06PHASE22025-04-012029-01-04
NCT04784715Trastuzumab Deruxtecan (T-DXd) With or Without Pertuzumab Versus Taxane, Trastuzumab and Pertuzumab in HER2-positive Metastatic Breast Cancer (DESTINY-Breast09)ACTIVE_NOT_RECRUITING2026-07-06PHASE32021-04-262029-12-30
NCT06567782A Study of Neoadjuvant Dostarlimab Plus Capecitabine Plus Oxaliplatin (CAPEOX) Vs CAPEOX With Previously Untreated T4N0 or Stage III Mismatch Repair Proficient (MMRp)/Microsatellite Stable (MSS) Colon CancerRECRUITING2026-07-06PHASE22025-02-172028-06-15
NCT06122779Study to Evaluate Safety, Tolerability and Drug Levels of BMS-986435/MYK-224 in Participants With Heart Failure With Preserved Ejection Fraction (HFpEF)RECRUITING2026-07-03PHASE22023-11-072026-07-03
NCT06843408A Ph1b/2 Study of Axatilimab Monotherapy in Chinese Participants With Recurrent or Refractory cGVHDRECRUITING2026-07-03PHASE1, PHASE22025-06-252027-12-31
NCT05702229Novel Combinations in Participants With Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction AdenocarcinomaRECRUITING2026-07-03PHASE22023-01-162027-07-01
NCT05966480Phase 2 Placebo-Controlled Study to Assess the Safety and Efficacy of ESK-001 in Active Systemic Lupus ErythematosusACTIVE_NOT_RECRUITING2026-07-01PHASE22023-06-262027-09-01
NCT06693895A Study on the Safety of an Investigational Chickenpox Vaccine, When Given to Healthy Children, 12 to 15 Months of AgeRECRUITING2026-07-01PHASE32024-11-262026-11-23
NCT04919980TVMR With the Innovalve System Trial - Early Feasibility StudyRECRUITING2026-07-01NA2022-09-012031-07-01
NCT05479812Dose Escalation and Expansion Study of WTX-124 as Monotherapy and in Combination With Pembrolizumab (Pembro) in Patients With Selected Advanced or Metastatic Solid TumorsRECRUITING2026-07-01PHASE12022-05-202026-07-31
NCT06617429Phase 3 Efficacy and Safety Study of GTX-102 in Pediatric Subjects With Angelman Syndrome (AS)ACTIVE_NOT_RECRUITING2026-07PHASE32024-12-032027-11
NCT03891446Long-term Safety and Efficacy Extension Trial of Bimatoprost SRACTIVE_NOT_RECRUITING2026-07PHASE32019-03-272026-08
NCT06848348Efficacy and Safety Study of Halneuron in the Treatment of Chemotherapy-Induced Neuropathic PainRECRUITING2026-07PHASE22025-02-212026-08
NCT06366464A Study of Pitolisant in Patients With Prader-Willi SyndromeRECRUITING2026-07PHASE32024-05-282027-07
NCT04544267Study on a High-Dose Quadrivalent Influenza Vaccine Compared With Standard-Dose Quadrivalent Influenza Vaccine in Children 6 Months Through 35 Months of AgeSUSPENDED2026-07PHASE32020-09-152026-07
NCT06750432PMN310 in Patients With Early Alzheimer's Disease (PRECISE-AD)RECRUITING2026-07PHASE12024-12-132026-12
NCT06921759A Study to Investigate the Efficacy and Safety of Lebrikizumab in Participants With Moderate-to-Severe Atopic Hand and Foot DermatitisRECRUITING2026-07PHASE32025-04-212026-09
NCT05839730Fast Induced Remodeling in Heart Failure With Preserved Ejection FractionRECRUITING2026-07NA2024-09-112027-07
NCT06606106A Study of LY3537031 in Overweight, Obese, and Healthy ParticipantsRECRUITING2026-07PHASE12024-09-052026-07
NCT06783621A Study to Evaluate Patient Satisfaction With the Overall Face and Neck Appearance After Combined Treatment of OnabotulinumtoxinA, JUVÉDERM® Products, KYBELLA, CoolSculpting Elite and SkinMedica ProductsRECRUITING2026-07PHASE42025-01-162026-07
NCT06101329Study of Lenacapavir and Emtricitabine/Tenofovir Disoproxil Fumarate (F/TDF) in Prevention of HIV in Cisgender Women in the United States (HPTN 102)ACTIVE_NOT_RECRUITING2026-07PHASE22023-11-172028-01
NCT05082571Study to Evaluate the Safety and Efficacy of Oral Vadadustat in Pediatric Participants With Anemia of Chronic Kidney DiseaseWITHDRAWN2026-07PHASE32025-012026-10
NCT07054684Study of BHV-1400 in IgA NephropathyRECRUITING2026-07PHASE12025-07-302026-07
NCT06566092Study of Autologous Tumor-Infiltrating Lymphocytes in Pediatric, Adolescent, and Young Adult ParticipantsRECRUITING2026-07PHASE12024-03-282028-07
NCT06689839Trial of the F2 Filter and Delivery System for Embolic Protection During TAVRNOT_YET_RECRUITING2026-07NA2025-03-012026-10
NCT05720117Study of PYX-201 in Solid TumorsRECRUITING2026-07PHASE12023-03-142027-05
NCT06959121CellFX® Nanosecond Pulsed Field Ablation (nsPFA)™ Cardiac Surgery Clamp System to Treat Atrial FibrillationNOT_YET_RECRUITING2026-07NA2025-072027-01
NCT07092813Pharmacokinetics of Sulopenem Etzadroxil Plus Probenecid in AdolescentsNOT_YET_RECRUITING2026-07PHASE12025-092026-07
NCT05082584Study to Evaluate the Safety and Efficacy of Oral Vadadustat in Pediatric Participants With Anemia of Chronic Kidney Disease Naive to Erythropoiesis-Stimulating AgentsWITHDRAWN2026-07PHASE32025-012026-10
NCT06521463SIMPLAAFY Clinical TrialRECRUITING2026-07NA2024-10-012027-01
NCT07123727A Study to Examine Anktiva for the Treatment of COVID-19.RECRUITING2026-07PHASE22025-092026-07
NCT07010471A Clinical Trial for Participants With DEE to Assess Efficacy, Safety, Tolerability, and PK of RelutrigineRECRUITING2026-07PHASE32025-07-092027-07
NCT06937203Study of ARO-ALK7 in Adult Volunteers With Obesity With and Without Type 2 Diabetes MellitusRECRUITING2026-07PHASE1, PHASE22025-05-072026-07
NCT06056297A Study of Mavorixafor in Participants With Congenital and Acquired Primary Autoimmune and Idiopathic Chronic Neutropenic Disorders Who Are Experiencing Recurrent and/or Serious InfectionsRECRUITING2026-07PHASE32024-06-062026-08
NCT07158437Phase 1 Study of SL-325 in Healthy VolunteersRECRUITING2026-07PHASE12025-092026-07
NCT06481891A Study to Evaluate the Efficacy and Safety of Sotagliflozin in Symptomatic Obstructive and Non-obstructive Hypertrophic CardiomyopathyRECRUITING2026-07PHASE32024-09-242026-08
NCT05005403Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer (NSCLC), Head and Neck Squamous Cell Carcinoma (HNSCC) and Other Solid Tumors, Receiving Intravenous (IV) Infusion of Azirkitug (ABBV-514) Alone or in Combination With Budigalimab or BevacizumabRECRUITING2026-07PHASE12021-11-012027-06
NCT06188585Randomized Trial of UI-EWD vs. Conventional Endoscopic Therapy for Nonvariceal Upper Gastrointestinal BleedingRECRUITING2026-07NA2024-06-212026-08
NCT06425159A Study to Determine if BHV-7000 is Effective and Safe in Adults With Idiopathic Generalized Epilepsy With Generalized Tonic-clonic SeizuresRECRUITING2026-07PHASE2, PHASE32024-06-202027-07
NCT07155668A Safety, Tolerability and Pharmacokinetics Study of VRDN-003 in Participants With Thyroid Eye Disease (TED)RECRUITING2026-07PHASE32025-07-012026-11
NCT06562907Study of GS-4571 in Healthy Participants, Nondiabetic Obese Participants, and Nonobese Participants With Type 2 Diabetes Mellitus (T2DM)RECRUITING2026-07PHASE12024-08-282026-07
NCT05650879ELVN-002 in HER2 Mutant Non-Small Cell Lung CancerACTIVE_NOT_RECRUITING2026-07PHASE12023-03-202026-07
NCT03519945A Study to Evaluate the Long-Term Efficacy and Safety of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 3)RECRUITING2026-07PHASE32018-07-182027-12
NCT03118505A Study of Infuse® Bone Graft With Mastergraft® Strip and Posterior Fixation for Posterolateral Fusion (PLF) Treatment of Multi-Level Degenerative Lumbosacral Spinal ConditionsACTIVE_NOT_RECRUITING2026-07NA2017-06-292026-12
NCT06470451Confirmatory Study of Topical HyBryte™ vs. Placebo for the Treatment of CTCLRECRUITING2026-07PHASE32025-01-072026-10
NCT07108153Proof-of-concept Study to Evaluate the Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of SION-719 When Added to TrikaftaNOT_YET_RECRUITING2026-07PHASE22025-102026-07
NCT06084481Study to Assess Adverse Events and Change in Disease Activity in Adult Participants With Select Advanced Solid Tumor Indications Receiving Intravenous (IV) ABBV-400RECRUITING2026-07PHASE12023-11-092026-07
NCT05552755Evaluate REC-4881 in Patients With FAPRECRUITING2026-07PHASE1, PHASE22023-07-102026-07
NCT07159828A Study to Assess AXN-2510 Treatment in Adult Patients With Advanced Solid TumorsRECRUITING2026-07PHASE12025-09-152027-05-15
NCT04184050Study of HPN217 in Participants With Relapsed/Refractory Multiple Myeloma MK-4002 (MK-4002-001)ACTIVE_NOT_RECRUITING2026-06-30PHASE12020-04-132026-06-30
NCT06537999A Clinical Study to Evaluate DNTH103 in Adults With Multifocal Motor NeuropathyRECRUITING2026-06-30PHASE22024-09-172028-03-31
NCT03706833Edwards PASCAL CLASP IID/IIF Pivotal Clinical TrialRECRUITING2026-06-30NA2018-11-302031-06-30
NCT06606847A Study to Investigate the Effects of Durvalumab With Oleclumab Following Chemoradiation in Participants With Locally Advanced Unresectable Non-Small Cell Lung Cancer (LADOGA)ACTIVE_NOT_RECRUITING2026-06-30PHASE22024-09-242027-06-30
NCT04150497Phase 1/2 Study of UCART22 in Patients With Relapsed or Refractory CD22+ B-cell Acute Lymphoblastic Leukemia (BALLI-01)RECRUITING2026-06-30PHASE1, PHASE22019-10-142026-06-30
NCT05221840A Global Study to Assess the Effects of Durvalumab With Oleclumab or Durvalumab With Monalizumab Following Concurrent Chemoradiation in Patients With Stage III Unresectable Non-Small Cell Lung CancerACTIVE_NOT_RECRUITING2026-06-30PHASE32022-02-072030-07-02
NCT06851806Study of Palivizumab in Children With High Risk of Severe Respiratory Syncytial Virus (RSV) DiseaseNOT_YET_RECRUITING2026-06-30NA2025-08-302026-06-30
NCT06637423A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Patients With Bladder Cancer (MK-2870-027)RECRUITING2026-06-30PHASE1, PHASE22024-12-202028-07-31
NCT05825365Selumetinib in Chinese Paediatric With Post-operative NF1-PNs, Phaseâ…ˇ, Double-Blinded, Placebo-Controlled StudyWITHDRAWN2026-06-30PHASE22023-08-312026-06-30
NCT06049212Sacituzumab Tirumotecan (MK-2870) as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors (MK-2870-008)RECRUITING2026-06-30PHASE12023-10-262027-01-29
NCT04939610A Study of 177Lu-FAP-2286 in Advanced Solid TumorsRECRUITING2026-06-30PHASE1, PHASE22021-07-302028-06-30
NCT04524000Study Assessing the Efficacy and Safety of Treatment With Alpelisib Plus Fulvestrant in Japanese Men and Postmenopausal Women With Advanced Breast CancerACTIVE_NOT_RECRUITING2026-06-30PHASE22021-01-082026-07-31
NCT04925479Study to Determine the Dose and Safety of Asciminib in Pediatric Patients With Chronic Myeloid LeukemiaRECRUITING2026-06-30PHASE1, PHASE22021-12-272031-11-01
NCT06016738OP-1250 (Palazestrant) vs. Standard of Care for the Treatment of ER+/HER2- Advanced Breast CancerRECRUITING2026-06-30PHASE32023-11-162027-09-30
NCT04855656Study of RP-6306 Alone or in Combination With RP-3500 or Debio 0123 in Patients With Advanced Solid TumorsRECRUITING2026-06-30PHASE12021-04-302026-12-31
NCT05911295Disitamab Vedotin With Pembrolizumab vs Chemotherapy in Previously Untreated Urothelial Cancer Expressing HER2RECRUITING2026-06-30PHASE32023-09-222029-04-30
NCT05818683A Study of JNJ-78278343 in Combination With Either JNJ-63723283 (Cetrelimab), Taxane Chemotherapy, or Androgen Receptor Pathway Inhibitors for Metastatic Prostate CancerRECRUITING2026-06-30PHASE12023-04-262027-09-01
NCT05511922PK Subtrial in Adolescent Patients With HAE Type I or II Participating in the KVD900-302 TrialACTIVE_NOT_RECRUITING2026-06-30PHASE32022-10-242026-06-30
NCT04406727UB-421 in Combination With Optimized Background Regimen in Patients With Multi-drug Resistant HIV-1 InfectionNOT_YET_RECRUITING2026-06-30PHASE32023-12-012026-06-30
NCT05701800A Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1468 in Healthy Adults ≥50 Years of AgeACTIVE_NOT_RECRUITING2026-06-30PHASE1, PHASE22023-01-232026-06-30
NCT05920356A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)RECRUITING2026-06-30PHASE32023-11-162031-06-30
NCT05505916An Open-label Extension Trial to Evaluate the Long-term Safety of KVD900 (Sebetralstat) for On-Demand Treatment of Angioedema Attacks in Adolescent and Adult Patients With Hereditary Angioedema (HAE)ACTIVE_NOT_RECRUITING2026-06-30PHASE32022-10-242026-06-30
NCT05208944THIO Sequenced With Cemiplimab in Advanced NSCLCRECRUITING2026-06-30PHASE22022-06-082026-12-31
NCT03742895Efficacy and Safety of Olaparib (MK-7339) in Participants With Previously Treated, Homologous Recombination Repair Mutation (HRRm) or Homologous Recombination Deficiency (HRD) Positive Advanced Cancer (MK-7339-002 / LYNK-002)ACTIVE_NOT_RECRUITING2026-06-30PHASE22018-12-122026-06-30
NCT04925024Evaluation of Lomecel-B™ Injection in Patients With Hypoplastic Left Heart Syndrome (HLHS): A Phase IIb Clinical Trial.ACTIVE_NOT_RECRUITING2026-06-30PHASE22021-06-252026-08-31
NCT06308120A Trial to Compare Robotic Assisted Bronchoscopy Ion's Clinical Utility for Peripheral Lung Nodule Access and Diagnosis to ENBRECRUITING2026-06-30NA2024-03-202026-09-30
NCT04892173JNJ-90301900 (NBTXR3) Activated by Radiotherapy With or Without Cetuximab in LA-HNSCCRECRUITING2026-06-30PHASE32022-01-042027-12-31
NCT06407934A Study to Evaluate the Treatment Response and Safety of Two Dose Regimens of Subcutaneous Amlitelimab Compared With Treatment Withdrawal in Participants Aged 12 Years and Older With Moderate-to-severe Atopic DermatitisRECRUITING2026-06-29PHASE32024-05-082027-04-05
NCT07074327Effects of VX-407 on the Pharmacokinetics of Oral Contraceptives in Healthy ParticipantsRECRUITING2026-06-29PHASE12025-07-112026-07-04
NCT03813407An Open-label Study to Assess Safety and Efficacy of SZC in Paediatric Patients With HyperkalaemiaRECRUITING2026-06-29PHASE32019-04-022026-06-29
NCT05440708A Study of TTI-101 as Monotherapy and in Combination in Participants With Locally Advanced or Metastatic, and Unresectable Hepatocellular CarcinomaRECRUITING2026-06-29PHASE1, PHASE22023-03-232027-06-28
NCT04906460Open-label Study of WVE-N531 in Patients With Duchenne Muscular Dystrophy (FORWARD-53)RECRUITING2026-06-27PHASE1, PHASE22021-09-282027-04-24
NCT06785012A Study to Explore the Efficacy of JNJ-89495120 in the Treatment of Major Depressive DisorderRECRUITING2026-06-26PHASE22024-12-262026-06-26
NCT05265273A Study of Nipocalimab in Children Aged 2 to Less Than 18 Years With Generalized Myasthenia GravisRECRUITING2026-06-26PHASE2, PHASE32022-07-202026-06-26
NCT05021835ZEUS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Cardiovascular Disease, Chronic Kidney Disease and InflammationACTIVE_NOT_RECRUITING2026-06-26PHASE32021-08-302026-06-26
NCT06372925Intravascular Imaging Study of the Effect of Inclisiran on Plaque in Patients With Acute Myocardial InfarctionRECRUITING2026-06-24PHASE42024-07-122026-06-24
NCT03975829Pediatric Long-Term Follow-up and Rollover StudyACTIVE_NOT_RECRUITING2026-06-23PHASE42019-11-042026-07-23
NCT07034690Study to Evaluate the Impact of a Targeted Lipid Optimization Program on LDL-C Control in At-risk Adult Patients With DyslipidemiaNOT_YET_RECRUITING2026-06-23PHASE42025-06-302027-06-30
NCT06698042A Clinical Study of Pembrolizumab (+) Berahyaluronidase Alfa (MK-3475A) to Treat Newly-diagnosed Metastatic Non-small Cell Lung Cancer (MK-3475A-F84)RECRUITING2026-06-22PHASE32024-11-212030-02-11
NCT04640025A Rollover Study to Provide Continued Treatment for Participants Previously Enrolled in Studies of ItacitinibACTIVE_NOT_RECRUITING2026-06-22PHASE22021-03-102026-06-22
NCT05624450Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental OxygenRECRUITING2026-06-19PHASE32022-12-132026-06-19
NCT06028230A Phase 2 Study to Evaluate the Efficacy and Safety of SAR444656 Compared With Placebo in Adult Participants With Moderate to Severe Hidradenitis SuppurativaACTIVE_NOT_RECRUITING2026-06-19PHASE22023-09-292026-07-17
NCT06104124A Study to Evaluate the Efficacy and Safety of Dazodalibep in Participants With Sjögren's Syndrome (SS) With Moderate-to-severe Systemic Disease ActivityACTIVE_NOT_RECRUITING2026-06-18PHASE32024-01-242026-08-19
NCT07105722A Trial to Evaluate the Safety and Immune Response of an Investigational Pneumococcal Vaccine in Adults 50 To 64 Years of AgeRECRUITING2026-06-18PHASE12025-08-122026-06-18
NCT06862791A Weight Loss Study Evaluating Subcutaneous Treatment With AZD9550 and AZD6234 in Combination Against Placebo or Each of the Drugs AloneACTIVE_NOT_RECRUITING2026-06-18PHASE22025-02-182026-06-18
NCT05600777A 24-Week Study of the Efficacy and Safety of BLU-5937 in Adults With Refractory Chronic CoughRECRUITING2026-06-17PHASE32022-12-052027-03-23
NCT06188520A First-in-human Dose Escalation and Expansion Study to Evaluate the Safety, and Tolerability of AZD8421 Alone or in Combination in Participants With Selected Advanced or Metastatic Solid TumorsRECRUITING2026-06-17PHASE1, PHASE22023-12-052026-06-17
NCT05731128A Study to Investigate the Efficacy and Safety of Dupilumab Therapy Compared With Placebo in Participants Aged ≥18 Years With Moderately to Severely Active Ulcerative Colitis With an Eosinophilic Phenotype (LIBERTY-UC SUCCEED (Study in UC for Clinical Efficacy Evaluation of Dupilumab))RECRUITING2026-06-17PHASE22023-01-122027-03-24
NCT05543616A Study to Learn About Variant-Adapted COVID-19 RNA Vaccine Candidate(s) in Healthy ChildrenRECRUITING2026-06-16PHASE2, PHASE32022-09-232026-06-16
NCT04185883Sotorasib Activity in Subjects With Advanced Solid Tumors With KRAS p.G12C Mutation (CodeBreak 101)RECRUITING2026-06-16PHASE12019-12-172027-12-05
NCT04208178Study of Alpelisib (BYL719) in Combination With Trastuzumab and Pertuzumab as Maintenance Therapy in Patients With HER2-positive Advanced Breast Cancer With a PIK3CA MutationACTIVE_NOT_RECRUITING2026-06-16PHASE32020-07-162026-06-16
NCT05742802Long-term Efficacy and Safety of Tozorakimab in Participants With Chronic Obstructive Pulmonary Disease With a History of Exacerbations (PROSPERO).RECRUITING2026-06-16PHASE32023-03-062026-08-17
NCT05851443A Study to Evaluate the Efficacy and Safety Study of Povorcitinib in Participants With Inadequately Controlled Moderate to Severe AsthmaRECRUITING2026-06-15PHASE22023-07-112027-01-31
NCT07153146Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of PN-881 in Healthy Subjects.NOT_YET_RECRUITING2026-06-15PHASE12025-09-082026-06-15
NCT05424822A Study of JNJ-80948543, a T-cell Redirecting CD79b x CD20 x CD3 Trispecific Antibody, in Participants With Non-Hodgkin Lymphoma (NHL) and Chronic Lymphocytic Leukemia (CLL)ACTIVE_NOT_RECRUITING2026-06-12PHASE12022-08-182027-07-30
NCT07045701FMXIN002 in Patients at Risk of AnaphylaxisENROLLING_BY_INVITATION2026-06-12PHASE2, PHASE32025-06-122026-07-12
NCT06450197Phase IIa Study Evaluating AZD7798 in Crohn's DiseaseRECRUITING2026-06-12PHASE22024-08-282027-08-02
NCT05714969A Study of TAK-755 (rADAMTS13) With Little to No Plasma Exchange (PEX) Treatment in Adults With Immune-mediated Thrombotic Thrombocytopenic Purpura (iTTP)RECRUITING2026-06-11PHASE22023-03-212026-06-11
NCT06417814A Study to Investigate the Efficacy and Safety of Dato-DXd With or Without Osimertinib Compared With Platinum Based Doublet Chemotherapy in Participants With EGFR-Mutated Locally Advanced or Metastatic Non-Small Cell Lung CancerRECRUITING2026-06-11PHASE32024-10-042028-05-29
NCT05750628Platform Study to Evaluate the Efficacy and Safety of Anti-malarial Agents in Patients With Uncomplicated Plasmodium Falciparum MalariaRECRUITING2026-06-09PHASE22024-01-232026-06-23
NCT06821750A Study to Learn How Different Amounts of the Study Medicine Called PF-07314470 Are Tolerated and Act in the Body in Healthy AdultsRECRUITING2026-06-09PHASE12025-02-112026-06-09
NCT06970405Study of Safety and Effects of Garetosmab in Healthy Obese Men and Post-Menopausal WomenWITHDRAWN2026-06-08PHASE12025-05-292026-06-08
NCT06299111A Trial to Learn How Well REGN9933 and REGN7508 Work for Preventing Blood Clots, and How Safe They Are, in Adults Who Have a Peripherally Inserted Central Catheter (PICC)RECRUITING2026-06-08PHASE22024-09-202026-06-08
NCT06384820Study of Cemiplimab Alone or in Combination With Fianlimab and/or Other Experimental Agents in Adult Participants With Peri-operative Stage III/IV Cutaneous Squamous Cell Carcinoma (CSCC)WITHDRAWN2026-06-08PHASE22024-11-142030-05-06
NCT06004661Study of Lutetium (177Lu) Vipivotide Tetraxetan in mCRPC Participants With Moderately and Severely Impaired and With Normal Renal FunctionRECRUITING2026-06-05PHASE22024-04-042026-08-04
NCT06973291A Study Comparing Zasocitinib (TAK-279) With Deucravacitinib in Adults With Plaque PsoriasisRECRUITING2026-06-05PHASE32025-07-092026-07-03
NCT03584165Long-term Safety and Efficacy Follow-up of BIIB111 for the Treatment of Choroideremia and BIIB112 for the Treatment of X-Linked Retinitis PigmentosaENROLLING_BY_INVITATION2026-06-04PHASE32018-06-042026-06-04
NCT06965465A Study to Learn How Different Amounts of the Study Medicine Called PF-07999415 Are Tolerated and Act in the Body in Healthy AdultsRECRUITING2026-06-04PHASE12025-06-202026-06-04
NCT04077463A Study of Lazertinib as Monotherapy or in Combination With Amivantamab in Participants With Advanced Non-small Cell Lung CancerACTIVE_NOT_RECRUITING2026-06-03PHASE12019-09-042026-06-03
NCT06312020A Phase 2 Study to Investigate Efficacy and Safety of HZN-1116 in Participants With Sjogren's SyndromeRECRUITING2026-06-02PHASE22024-05-092027-02-09
NCT06534411A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Tirzepatide in People With Type 2 Diabetes Treated With Metformin, SGLT2 Inhibitor or BothACTIVE_NOT_RECRUITING2026-06-02PHASE32024-11-052026-07-14
NCT07017725A Dose-escalation Study Followed by a Dose Optimal Study to Evaluate the Safety and Efficacy of CID-103 in Adults With Chronic Immune ThrombocytopeniaRECRUITING2026-06-01PHASE1, PHASE22025-01-032026-12-30
NCT06859073A Research Study to Evaluate the Safety of NNC4004-0002 When Given to Participants With Asymptomatic HyperuricemiaRECRUITING2026-06-01PHASE12024-11-132026-06-01
NCT07198139A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of CDI-988 in Healthy Adults After Challenge With Snow Mountain VirusNOT_YET_RECRUITING2026-06-01PHASE1, PHASE22025-11-012026-10-01
NCT05853458Evaluation of HU-resistance in Adult Patients With Polycythemia Vera Who Meet PV-AIM PredictorsACTIVE_NOT_RECRUITING2026-06-01PHASE42023-07-282027-01-27
NCT07086079A Study of Doravirine/Islatravir in Healthy Lactating Females (MK-8591A-061)RECRUITING2026-06-01PHASE12025-09-262026-06-01
NCT06239467First-in-Human Study of OKI-219 in Advanced Solid Tumors and Advanced Breast CancerRECRUITING2026-06-01PHASE12024-02-262027-08-01
NCT06064929A Study to Learn More About the Safety and Effects of Felzartamab in Adults With Lupus Nephritis Aged 18 to 75 Years OldRECRUITING2026-06-01PHASE1, PHASE22023-11-012026-06-01
NCT05701306APG-115 Alone or in Combination With APG-2575 in Children With Recurrent or Refractory Neuroblastoma or Solid TumorsRECRUITING2026-06-01PHASE12023-02-282027-12-31
NCT056295594D-310 in Adults With Fabry Disease and Cardiac InvolvementRECRUITING2026-06PHASE1, PHASE22022-10-162030-06
NCT06603077A Study to Evaluate the Efficacy and Safety of AVTX-009 in Patients With Moderate to Severe Hidradenitis SuppurativaRECRUITING2026-06PHASE22024-09-162026-07
NCT03257033Intra-arterial Gemcitabine vs. IV Gemcitabine and Nab-Paclitaxel Following Radiotherapy for LAPCRECRUITING2026-06PHASE32018-03-122026-09
NCT06127199Contraceptive Efficacy Study of OvapreneRECRUITING2026-06NA2023-12-192026-09
NCT065535474-Week, Multi-center Dose-Ranging Study for the IBS-C in Pts. 6 to <12 YrsRECRUITING2026-06PHASE22024-07-242026-06
NCT045171494D-125 in Patients With X-Linked Retinitis Pigmentosa (XLRP)ACTIVE_NOT_RECRUITING2026-06PHASE1, PHASE22020-06-092029-05
NCT06998056Safety Study of Roflumilast Cream 0.05% in Infants Aged 3 Months to Less Than 2 Years With Atopic DermatitisRECRUITING2026-06PHASE22025-06-092026-06
NCT05900908Post-operative Adjuvant Therapy w/wo GammaTile + Systemic TherapyWITHDRAWN2026-06PHASE42025-052028-06
NCT06603571A Study to Investigate Weight Management With LY3841136 and Tirzepatide (LY3298176), Alone or in Combination, in Adult Participants With Obesity or Overweight With Type 2 DiabetesACTIVE_NOT_RECRUITING2026-06PHASE22024-09-202026-08
NCT04708834Long-term Safety Study of Adjunctive Troriluzole in Subjects With Obsessive Compulsive DisorderENROLLING_BY_INVITATION2026-06PHASE32021-03-302026-06
NCT05281471Efficacy & Safety of Olvi-Vec and Platinum-doublet + Bevacizumab Compared to Physician's Choice of Chemotherapy and Bevacizumab in Platinum-Resistant/Refractory Ovarian Cancer (PRROC) (OnPrime, GOG-3076)RECRUITING2026-06PHASE32022-08-312026-10
NCT04905693Extension Study of Inhaled Treprostinil in Subjects With Fibrotic Lung DiseaseENROLLING_BY_INVITATION2026-06PHASE32022-09-062026-06
NCT06759389The VENTOR Clinical StudyRECRUITING2026-06NA2025-04-042026-06
NCT05280093HEAL-IST IDE TrialRECRUITING2026-06NA2022-05-312027-06
NCT06587282PREEMIE: Study for Treatment of PDA in Premature InfantsRECRUITING2026-06NA2025-03-062026-06
NCT06739811Clinical Evaluation of the Medtronic Implantable Insulin Pump System (MIIPS 2020) in Adult Subjects With Type 1 Diabetes (CIP347)RECRUITING2026-06NA2025-03-262027-01
NCT06081894Phase 3 Trial to Evaluate the Efficacy and Safety of Aficamten Compared to Placebo in Adults With Symptomatic nHCMRECRUITING2026-06PHASE32023-08-302026-09
NCT06347016Study of Plozasiran in Adults With Severe HypertriglyceridemiaACTIVE_NOT_RECRUITING2026-06PHASE32024-07-232026-09
NCT06382155A Phase 2 Study of Vosoritide in Children with Idiopathic Short StatureRECRUITING2026-06PHASE22024-10-212036-12
NCT03715933Phase 1 Study of INBRX-109 in Subjects with Locally Advanced or Metastatic Solid Tumors Including SarcomasRECRUITING2026-06PHASE12018-10-102026-12
NCT06210945Study to Evaluate the Safety, Tolerability, and Activity of CM-101 in Patients With Systemic SclerosisSUSPENDED2026-06PHASE22024-092026-12
NCT07035990Safety, Tolerability, and Pharmacokinetics of Multiple Dose Combinations of SION-451 and Complementary Modulators SION-2222 and SION-109 in Healthy Participants.RECRUITING2026-06PHASE12025-07-232026-06
NCT06480565A Phase 1/2 Trial of ADI-270 in ccRCCACTIVE_NOT_RECRUITING2026-06PHASE1, PHASE22024-12-122027-06
NCT06347003Study of Plozasiran (ARO-APOC3) in Adults With Severe HypertriglyceridemiaACTIVE_NOT_RECRUITING2026-06PHASE32024-07-222026-09
NCT06901505To Evaluate the Efficacy of Three Times Weekly (TIW) Vadadustat Compared to Standard of Care ESA in Patients With Anemia of CKD Receiving In-Center HemodialysisRECRUITING2026-06PHASE32025-07-242026-06
NCT05585320A Phase 1/2a Study of IMM-1-104 in Participants With Advanced or Metastatic Solid TumorsACTIVE_NOT_RECRUITING2026-06PHASE1, PHASE22022-10-312027-06
NCT06419205A Phase 2 Study to Evaluate the Safety, PD, PK, and Clinical Activity of ADX-097 in Participants With IgAN, LN or C3GWITHDRAWN2026-06PHASE22024-06-272026-06
NCT06698939ORKA-001 in Healthy VolunteersACTIVE_NOT_RECRUITING2026-06PHASE12024-12-192026-06
NCT06060665Intended to Determine the Effects of Seladelpar on Normalization of Alkaline Phosphatase Levels in Subjects With Primary Biliary Cholangitis (PBC)ACTIVE_NOT_RECRUITING2026-06PHASE32023-09-052026-06
NCT04567550RGX-314 Gene Therapy Administered in the Suprachoroidal Space for Participants With Diabetic Retinopathy (DR) With and Without Center Involved-Diabetic Macular Edema (CI-DME)ACTIVE_NOT_RECRUITING2026-06PHASE22020-11-202026-12
NCT06625320Phase 3 Study of Daraxonrasib (RMC-6236) in Patients With Previously Treated Metastatic Pancreatic Ductal Adenocarcinoma (PDAC)RECRUITING2026-06PHASE32024-10-162027-12
NCT04768972FUSION: A Study to Evaluate the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of ION363 in Amyotrophic Lateral Sclerosis Participants With Fused in Sarcoma Mutations (FUS-ALS)ACTIVE_NOT_RECRUITING2026-06PHASE32021-06-142028-03
NCT05547464Safety and Immune Responses After Vaccination With Two Investigational RNA-based Vaccines Against Tuberculosis in BCG Vaccinated VolunteersRECRUITING2026-06PHASE1, PHASE22023-07-312027-05
NCT06843590A Study to Evaluate the Safety and Effectiveness of ALKS 2680 in Subjects With Idiopathic HypersomniaRECRUITING2026-06PHASE22025-05-222026-06
NCT07012395A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative ColitisRECRUITING2026-06PHASE22025-05-272028-03
NCT06365853A Study of Ocular Toxicity Evaluation and Mitigation During Treatment With Mirvetuximab Soravtansine in Participants With Recurrent Ovarian Cancer With High Folate Receptor-Alpha ExpressionRECRUITING2026-06PHASE22024-07-292027-06
NCT03911505ZIP Study-OL Study of Safety, PK, Efficacy, PD, Immunogenicity of ATB200/AT2221 in Pediatrics Aged 0 to < 18 y.o. w/LOPDRECRUITING2026-06PHASE32020-02-132026-06
NCT06982963Randomized, Double Blind, Placebo-controlled Phase 2 Study in Adults With Celiac DiseaseRECRUITING2026-06PHASE22025-08-042026-06
NCT05462106A Study to Assess the Effects of ACI-24.060 in Alzheimer's Disease and in Down Syndrome (ABATE Study)RECRUITING2026-06PHASE1, PHASE22022-06-212026-06
NCT07073170A Study of LY3549492 in Chinese Participants With Type 2 Diabetes MellitusNOT_YET_RECRUITING2026-06PHASE12025-082026-06
NCT06739122A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)RECRUITING2026-06PHASE32025-01-102026-07
NCT06749054Evaluation of Long-Acting Lenacapavir for the Treatment of HIV-1 in Treatment-experienced Adolescents and ChildrenRECRUITING2026-06PHASE22025-03-262026-12
NCT06310291VTP-1000 in Adults With Celiac DiseaseRECRUITING2026-06EARLY_PHASE12024-08-012026-06
NCT06568042Effects of LY3848575 Versus Placebo in Participants With Painful Distal Sensory PolyneuropathyRECRUITING2026-06PHASE22024-08-222026-09
NCT06692283A Phase 3 Study Evaluating the Safety and Efficacy of Denifanstat in Patients With MASLD and MASHWITHDRAWN2026-06PHASE32025-032027-06
NCT06927999An Outpatient Study of the Efficacy of ARS-2 in Patients With Chronic Spontaneous UrticariaRECRUITING2026-06PHASE22025-07-092026-06
NCT04663308A Study to Evaluate Efficacy and Safety of an Investigational Drug Named Volixibat in Patients With Itching Caused by Primary Sclerosing Cholangitis (PSC)ACTIVE_NOT_RECRUITING2026-06PHASE22020-12-182027-04
NCT05599984Study to Evaluate Adverse Events, Change in Disease Activity, and How ABBV-706 Moves Through the Body When Intravenously (IV) Infused Alone or in Combination With IV Infused Budigalimab, Cisplatin, or Carboplatin in Adult Participants With Advanced Solid TumorsRECRUITING2026-06PHASE12022-12-052026-06
NCT03406611Pegtibatinase As an Enzyme Therapy for Patients with Homocystinuria Caused by Cystathionine Beta-Synthase Deficiency (COMPOSE)ACTIVE_NOT_RECRUITING2026-06PHASE1, PHASE22019-01-222026-12
NCT07019922A Clinical Trial of Elsunersen in Pediatric SCN2A-DEE to Assess Efficacy and SafetyRECRUITING2026-06PHASE32025-08-132028-12
NCT05611632Does Screening With the Galleri Test in the NHS Reduce the Likelihood of a Late-stage Cancer Diagnosis in an Asymptomatic Population? A Randomised Clinical TrialACTIVE_NOT_RECRUITING2026-06NA2021-08-312030-07
NCT06018428A Phase 2a Proof-of-Concept Trial of Bempikibart (ADX-914) for the Treatment of Severe Alopecia Areata (SIGNAL-AA)RECRUITING2026-06PHASE22023-09-122026-09
NCT04626518Substudy 03B: A Study of Immune and Targeted Combination Therapies in Participants With Second Line Plus (2L+) Renal Cell Carcinoma (MK-3475-03B/KEYMAKER-U03)ACTIVE_NOT_RECRUITING2026-05-31PHASE1, PHASE22020-12-172026-05-31
NCT05339126RNS System LGS Feasibility StudyRECRUITING2026-05-31PHASE22022-10-042026-12-31
NCT06940440IFx-Hu2.0 As An Adjunctive Therapy To Pembrolizumab In Advanced Or Metastatic Merkel Cell Carcinoma (MCC)NOT_YET_RECRUITING2026-05-31PHASE12025-04-302028-05-31
NCT04626479Substudy 03A: A Study of Immune and Targeted Combination Therapies in Participants With First Line (1L) Renal Cell Carcinoma (MK-3475-03A)ACTIVE_NOT_RECRUITING2026-05-31PHASE1, PHASE22020-12-162026-05-31
NCT06991270OMNI 3.1 Surgical System in Subjects With Primary Open-Angle GlaucomaRECRUITING2026-05-31NA2025-10-312026-05-31
NCT05312879Phase 2/3 Adaptive Study of VX-147 in Adult and Pediatric Participants With APOL1- Mediated Proteinuric Kidney DiseaseRECRUITING2026-05-31PHASE2, PHASE32022-03-302026-06-30
NCT04496349A Study Evaluating APG-115 as a Single Agent or in Combination With APG-2575 in Subjects With R/R T-PLL and NHLRECRUITING2026-05-31PHASE22021-07-122027-05-31
NCT06664619A Randomized, Double-Blind, Placebo-Controlled Trial on Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Combination in Participants 12 Years and Older With AsthmaRECRUITING2026-05-31PHASE32024-12-122026-05-31
NCT04817007A Study to Assess the Safety and Tolerability of BMS-986158 Alone and in Combination With Either Ruxolitinib or Fedratinib in Participants With Blood Cancer (Myelofibrosis)ACTIVE_NOT_RECRUITING2026-05-31PHASE1, PHASE22021-03-222026-05-31
NCT06003231A Study of Disitamab Vedotin in Previously Treated Solid Tumors That Express HER2ACTIVE_NOT_RECRUITING2026-05-31PHASE22023-11-142028-05-31
NCT05919238Padeliporfin VTP Treatment for Unresectable Pancreatic AdenocarcinomaRECRUITING2026-05-30PHASE12024-05-152026-10-30
NCT05270668Phase 2 Safety and Efficacy Study of Tulisokibart (MK-7240/PRA023) in Subjects With Systemic Sclerosis Associated With Interstitial Lung Disease (SSc-ILD) (MK-7240-007)ACTIVE_NOT_RECRUITING2026-05-30PHASE22022-03-292029-07-31
NCT06666699RIVOS Feasibility (MBO)WITHDRAWN2026-05-30NA2025-08-312026-05-30
NCT07142707A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MBX 4291 in Adult Participants With ObesityRECRUITING2026-05-30PHASE12025-09-032026-05-30
NCT05983068A Study of Long-term Effect of Dupilumab on Skin Barrier Function in Pediatric Participants With Atopic DermatitisACTIVE_NOT_RECRUITING2026-05-29PHASE42024-02-222026-08-07
NCT07207408Immunogenicity, Safety, and Tolerability of rF1V-1018 Vaccine in Adults 18 to 55 Years of AgeRECRUITING2026-05-29PHASE22025-09-112026-10-16
NCT03847428Assess Efficacy and Safety of Durvalumab Alone or Combined With Bevacizumab in High Risk of Recurrence HCC Patients After Curative TreatmentACTIVE_NOT_RECRUITING2026-05-29PHASE32019-04-292027-05-31
NCT05379985Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RASRECRUITING2026-05-29PHASE12022-05-312026-06-30
NCT03701334A Trial to Evaluate Efficacy and Safety of Ribociclib With Endocrine Therapy as Adjuvant Treatment in Patients With HR+/HER2- Early Breast CancerACTIVE_NOT_RECRUITING2026-05-29PHASE32018-12-072026-05-29
NCT05791201A Safety, Tolerability, and Efficacy Study of VX-264 in Participants With Type 1 DiabetesACTIVE_NOT_RECRUITING2026-05-29PHASE1, PHASE22023-05-162026-05-29
NCT06907511Study to Evaluate the Safety and the Immunogenicity of a Second Generation Structurally Designed mRNA Vaccine Candidate Against Pandemic Influenza H5 HA Strain in Healthy Adult Participants Aged 18 Years and OlderACTIVE_NOT_RECRUITING2026-05-28PHASE1, PHASE22025-04-172026-05-28
NCT05918250mRNA-2736 for Participants With Relapsed or Refractory Multiple Myeloma (RRMM)WITHDRAWN2026-05-27PHASE12023-08-152026-05-27
NCT06130553A Study of AZD3470, a PRMT5 Inhibitor, in Patients With MTAP Deficient Advanced/Metastatic Solid TumorsRECRUITING2026-05-27PHASE1, PHASE22024-01-182026-05-27
NCT06878404A Study to Evaluate the Efficacy and Safety of JNJ-77242113 (Icotrokinra) in Biologic-naĂŻve Participants With Active Psoriatic ArthritisRECRUITING2026-05-27PHASE32025-02-212028-11-21
NCT06252285Efficacy, Immunogenicity, and Safety Study of a Respiratory Syncytial Virus Vaccine in Infants and ToddlersACTIVE_NOT_RECRUITING2026-05-27PHASE32024-02-062027-12-07
NCT05095727A Study of mRNA-3745 in Adult and Pediatric Participants With Glycogen Storage Disease Type 1a (GSD1a)RECRUITING2026-05-26PHASE1, PHASE22022-06-012028-12-26
NCT06241118A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab on Background Topical Corticosteroids Therapy in Participants Aged 12 Years and Older With Moderate-to-severe AD Who Have Had an Inadequate Response to Prior Biologic Therapy or an Oral JAK InhibitorRECRUITING2026-05-25PHASE32024-02-292026-09-14
NCT06666491An Interventional Study to Compare the Efficacy and Safety of Tafenoquine (TQ) and Primaquine (PQ) When Either Are Taken Together With Chloroquine (CQ) for the Treatment of P. Vivax Malaria in Indian Participants Aged 2 Years and OlderRECRUITING2026-05-25PHASE32024-11-132026-05-25
NCT06685835A Study of the Efficacy and Safety of Brensocatib in Adults With Moderate to Severe Hidradenitis Suppurativa (HS)RECRUITING2026-05-22PHASE22024-12-162027-01-28
NCT05076175A Study Investigating Oral Ozanimod (RPC1063) in Pediatric Participants With Moderate to Severe Active Ulcerative ColitisRECRUITING2026-05-22PHASE2, PHASE32022-05-302031-08-14
NCT04779320A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Crohn's Disease (CD)RECRUITING2026-05-22PHASE32022-04-302026-05-22
NCT07072728Psilocybin-Assisted Psychotherapy in Cancer Patients With Adjustment DisorderRECRUITING2026-05-21PHASE22025-09-152026-08-21
NCT04938817Safety and Efficacy Study of Investigational Agents as Monotherapy or in Combination With Pembrolizumab (MK-3475) for the Treatment of Extensive-Stage Small Cell Lung Cancer (ES-SCLC) in Need of Second-Line Therapy (MK-3475-B98/KEYNOTE-B98)RECRUITING2026-05-20PHASE1, PHASE22021-08-192029-12-10
NCT03937154Study of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects With Non-small Cell Lung Cancer (NSCLC), Ovarian Cancer, or Breast CancerRECRUITING2026-05-20PHASE32020-02-262027-05-20
NCT06444113Concentration of Ofatumumab in the Breast Milk of Lactating Women With Relapsing Forms of Multiple SclerosisRECRUITING2026-05-18PHASE42024-11-252027-02-23
NCT05280548A Study to Evaluate the Effect of Venglustat Tablets on Left Ventricular Mass Index in Male and Female Adult Participants With Fabry DiseaseACTIVE_NOT_RECRUITING2026-05-15PHASE32022-05-032027-12-06
NCT06555419A Study to Find Out How Nusinersen is Processed in the Body When Given Through the ThecaFlex DRx™ System in Adult and Pediatric Participants With Spinal Muscular Atrophy (PIERRE-PK)RECRUITING2026-05-15PHASE12025-01-162026-05-15
NCT06685185A Research Study of a New Medicine NNC0363-1063 in Healthy Participants and Participants With Type 1 DiabetesRECRUITING2026-05-15PHASE12024-11-122026-05-15
NCT05399888A Study to Learn About the Safety of BIIB080 Injections and Whether They Can Improve Symptoms of Participants With Mild Cognitive Impairment Due to Alzheimer's Disease (AD) or Mild AD Dementia Between 50 to 80 Years of AgeACTIVE_NOT_RECRUITING2026-05-14PHASE22022-08-242029-01-08
NCT06194825EPIC-ATTR: A Study to Evaluate the Effect of Eplontersen on the Transthyretin Reduction and Long-term Safety in Chinese Subjects With Transthyretin Amyloid CardiomyopathyACTIVE_NOT_RECRUITING2026-05-14PHASE32023-12-012027-01-05
NCT06616415A Clinical Study to Evaluate the Pharmacokinetics, Efficacy, and Safety of Belumosudil in Chinese Adolescents With cGVHD Who Have Had an Inadequate Response to Glucocorticoids or Other Systemic TherapiesACTIVE_NOT_RECRUITING2026-05-13PHASE42024-12-042026-05-13
NCT06299098A Study to Test if Trevogrumab or Trevogrumab With Garetosmab When Taken With Semaglutide is Safe and How Well They Work in Adult Patients With Obesity for Weight Loss, Fat Loss, and Lean Mass PreservationACTIVE_NOT_RECRUITING2026-05-13PHASE22024-03-132026-11-04
NCT03374657A First-in-human, Proof of Concept Study of CPK850 in Patients With RLBP1 Retinitis PigmentosaACTIVE_NOT_RECRUITING2026-05-11PHASE1, PHASE22018-08-222026-05-11
NCT06625177A Trial to Test the Safety and Efficacy of TEV-53408 in Treating VitiligoRECRUITING2026-05-09PHASE12024-11-112027-06-05
NCT06137144AZD3470 as Monotherapy and in Combination With Anticancer Agents in Participants With Relapsed/Refractory Haematologic Malignancies.RECRUITING2026-05-08PHASE1, PHASE22024-01-232026-05-08
NCT06806046Anti-CEACAM5 ADC M9140 in Chinese Participants With Solid Tumors (PROCEADE-CRC-02)RECRUITING2026-05-07PHASE12024-12-202026-05-07
NCT06550076A Study of TAK-279 in Participants With Moderate-to-Severe Plaque PsoriasisRECRUITING2026-05-07PHASE32024-09-042026-05-07
NCT06448247A Study of SPY001-001 in Healthy VolunteersACTIVE_NOT_RECRUITING2026-05-05PHASE12024-06-062026-05-05
NCT06239116A Study of RM-718 in Healthy Subjects and in Patients With HORECRUITING2026-05-04PHASE12024-03-052026-05-04
NCT06681324Study Evaluating AZD7798 for Treatment in Crohn's Disease Patients With an IleostomyRECRUITING2026-05-04PHASE22024-12-112027-06-18
NCT06649630A Study Looking at How Different Doses of Study Medicine (Inno8) Works in the Body of Healthy MenRECRUITING2026-05-04PHASE12024-09-232026-05-04
NCT06829823Clinical Trial of Ablation Therapy in Participants With Intermediate-Risk Non-Muscle Invasive Papillary Bladder CancerNOT_YET_RECRUITING2026-05-01PHASE22025-05-012029-05-01
NCT06944717A Trial of a Norovirus G1.1 and G2.4 Vaccine Administered Orally to Healthy Participants Aged ≥ 18 Years and ≤ 80 Years OldACTIVE_NOT_RECRUITING2026-05-01PHASE12025-03-032026-05-01
NCT06228924Open-label, Dose Escalation Study of Safety and Preliminary Efficacy of TN-401 in Adults With PKP2 Mutation-associated ARVCRECRUITING2026-05-01PHASE12024-03-262029-10-01
NCT04790344LUX-Dx TRENDS Evaluates Diagnostics Sensors in Heart Failure Patients Receiving Boston Scientific's Investigational ICM System.ACTIVE_NOT_RECRUITING2026-05NA2021-03-202026-06
NCT05934097FT596 in Combination With R-CHOP in Subjects With B-Cell LymphomaWITHDRAWN2026-05PHASE12022-122039-05
NCT05732831Safety and Tolerability of TNG462 in Patients With MTAP-deleted Solid TumorsRECRUITING2026-05PHASE1, PHASE22023-05-262026-09
NCT06170606POLARx Post Approval Study (POLARx PAS)RECRUITING2026-05NA2024-06-282029-05
NCT05610891Novel Targeted Radiotherapy in Pediatric Patients With Inoperable Relapsed or Refractory HGGACTIVE_NOT_RECRUITING2026-05PHASE12023-10-012026-09
NCT05329649Evaluation of Safety and Efficacy of CTX001 in Pediatric Participants With Severe Sickle Cell Disease (SCD)RECRUITING2026-05PHASE32022-05-022026-05
NCT06347133Phase 3 Study of Plozasiran in Adults With HypertriglyceridemiaACTIVE_NOT_RECRUITING2026-05PHASE32024-05-212026-09
NCT05356195Evaluation of Safety and Efficacy of CTX001 in Pediatric Participants With Transfusion-Dependent β-Thalassemia (TDT)RECRUITING2026-05PHASE32022-05-032026-05
NCT07082816Reformulated PG324 Ophthalmic Solution for Intraocular Pressure ReductionRECRUITING2026-05PHASE32025-09-022026-05
NCT06687070APG-2449 Monotherapy or in Combination With PLD in Patients With Platinum-resistant Recurrent OC or Advanced STRECRUITING2026-05PHASE12024-12-172027-05
NCT06493383Lotrafilcon B Plano Cosmetic Contact Lenses StudyWITHDRAWN2026-05NA2025-012026-05
NCT05929079A Study of Retatrutide (LY3437943) in Participants With Type 2 Diabetes Mellitus Who Have Obesity or OverweightACTIVE_NOT_RECRUITING2026-05PHASE32023-07-112026-05
NCT06816992ORIC-114 in Combination with Subcutaneous Amivantamab in Patients with EGFR Exon20 Insertion Mutant NSCLCRECRUITING2026-05PHASE12025-02-272027-05
NCT05125302Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)RECRUITING2026-05PHASE32022-01-132026-05
NCT05101096Study of Sacituzumab Govitecan (SG) in Japanese Participants With Advanced Solid TumorsACTIVE_NOT_RECRUITING2026-05PHASE1, PHASE22021-10-202026-05
NCT06885177TECTONIC CAD IVL IDE StudyRECRUITING2026-05NA2025-04-012028-06
NCT05874414Combination of GNS561 and Trametinib in Patients With Advanced KRAS Mutated CholangiocarcinomaRECRUITING2026-05PHASE1, PHASE22023-08-212026-10
NCT06047548A Study of LY3298176 (Tirzepatide) For the Maintenance of Body Weight Reduction in Participants Who Have Obesity or Overweight With Weight-Related ComorbiditiesACTIVE_NOT_RECRUITING2026-05PHASE32023-09-202026-05
NCT06924970A Dose-Finding Study of Tebapivat to Assess Efficacy, and Safety in Participants With Sickle Cell Disease (SCD)RECRUITING2026-05PHASE22025-05-012027-05
NCT05182697SCI-210 in the Treatment of Children and Young Adults With AutismEvaluate the Safety, Tolerability and Efficacy of SCI-210 in Children With Autism Spectrum Disorder (ASD)RECRUITING2026-05NA2024-02-212026-06
NCT06075667A Study of Tirzepatide (LY3298176) Once Weekly in Adolescent Participants Who Have Obesity or Overweight With Weight-Related ComorbiditiesACTIVE_NOT_RECRUITING2026-05PHASE32023-10-162029-07
NCT04819100A Study of Selpercatinib After Surgery or Radiation in Participants With Non-Small Cell Lung Cancer (NSCLC)ACTIVE_NOT_RECRUITING2026-05PHASE32021-12-202028-05
NCT06513312Study of Lenacapavir Taken Twice a Year for HIV Pre-Exposure Prophylaxis (PrEP)ACTIVE_NOT_RECRUITING2026-05PHASE22024-10-072028-12
NCT06058013Study to Assess the Effects of Oral NMRA-335140 Versus Placebo in Participants With Major Depressive DisorderRECRUITING2026-05PHASE32023-12-202026-06
NCT05424484Mesh Augmented Reinforcement of Abdominal Wall Suture Line to Limit the Rate of Incisional Hernia OccurrenceACTIVE_NOT_RECRUITING2026-05NA2022-11-222028-09
NCT05546268Study of Oral MRT-2359 in Selected Cancer PatientsRECRUITING2026-05PHASE1, PHASE22022-10-122027-11
NCT04248439Gene Therapy for Fanconi Anemia, Complementation Group AACTIVE_NOT_RECRUITING2026-05PHASE22020-07-152026-05
NCT05718557Study of PYX-106 in Solid TumorsACTIVE_NOT_RECRUITING2026-05PHASE12023-05-232026-05
NCT07044674A Cataract Surgery Clinical TrialNOT_YET_RECRUITING2026-05NA2026-022026-06
NCT03105102A Study of the Efficacy and Safety of Risankizumab in Participants With Crohn's DiseaseACTIVE_NOT_RECRUITING2026-05PHASE32018-04-092026-05
NCT05965167Assess Safety and Compare PK of New Oral hPTH(1-34) Tablet Formulations vs. EBP05 Tablets and Subcutaneous ForteoACTIVE_NOT_RECRUITING2026-05PHASE1, PHASE22023-05-112026-05
NCT04624698iStent Inject New Enrollment Post-Approval StudyACTIVE_NOT_RECRUITING2026-05NA2020-09-222026-05
NCT06982846A Study to Investigate the Response of Participants With Type 2 Diabetes Mellitus on Once-Weekly Retatrutide to HypoglycemiaRECRUITING2026-05PHASE12025-06-062026-05
NCT06005792Multiple Ascending-Dose Study of XmAb®27564 in Patients With Psoriasis or Atopic DermatitisACTIVE_NOT_RECRUITING2026-05PHASE12022-10-102026-05
NCT05645107A Study to Evaluate Efficacy, Safety, and PK of XEMBIFY®+Standard Medical Treatment (SMT) Compared to Placebo+SMT to Prevent Infections in Participants With HGG and Recurrent or Severe Infections Associated With B-cell Chronic Lymphocytic Leukemia, Multiple Myeloma, and Non-Hodgkin LymphomaRECRUITING2026-05PHASE32022-12-262026-06
NCT07177066A Study of EDG-15400 in Healthy AdultsRECRUITING2026-05PHASE12025-08-202026-05
NCT05784246A Study of Mirikizumab (LY3074828) in Pediatric Participants With Moderately to Severely or Active Ulcerative ColitisRECRUITING2026-05PHASE32023-11-222026-08
NCT07136103A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Immunogenicity of ABBV-277 in Healthy Adult ParticipantsRECRUITING2026-05PHASE12025-08-192026-05
NCT03952078A Dose Escalation Study Evaluating CPI-818 in Relapsed/Refractory T-Cell LymphomaACTIVE_NOT_RECRUITING2026-04-30PHASE12019-05-032026-04-30
NCT04612751Phase 1b Study of Dato-DXd in Combination With Immunotherapy With or Without Carboplatin in Advanced or Metastatic Non-Small Cell Lung CancerACTIVE_NOT_RECRUITING2026-04-30PHASE12021-02-022026-04-30
NCT06619860Evaluation of Efficacy and Safety of VX-993 for Pain Associated With Diabetic Peripheral NeuropathyRECRUITING2026-04-30PHASE22024-10-182026-05-30
NCT05203510A Study of a Mean Pulmonary Artery Pressure-Targeted Approach With Early and Rapid Treprostinil Therapy to Reverse Right Ventricular Remodeling in Participants With Pulmonary Arterial HypertensionACTIVE_NOT_RECRUITING2026-04-30PHASE42022-10-202028-04-30
NCT06897748A Study to Investigate Efficacy and Safety of Tozorakimab Injections Compared With Placebo in Adult Participants With Symptomatic Chronic Obstructive Pulmonary Disease (COPD) With a History of COPD Exacerbations and Elevated EosinophilsRECRUITING2026-04-30PHASE22025-04-122026-04-30
NCT04960709Treatment Combination of Durvalumab, Tremelimumab and Enfortumab Vedotin or Durvalumab and Enfortumab Vedotin in Patients With Muscle Invasive Bladder Cancer Ineligible to Cisplatin or Who Refuse CisplatinACTIVE_NOT_RECRUITING2026-04-30PHASE32021-08-052028-09-08
NCT06040541Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid TumorsRECRUITING2026-04-30PHASE12023-09-072027-04-30
NCT05156281Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS)RECRUITING2026-04-30PHASE32021-12-132030-10-30
NCT04494412An Intravenous (IV) Zanamivir Pharmacokinetics (PK) Study in Hospitalized Neonates and Infants With Influenza InfectionRECRUITING2026-04-30PHASE22022-11-212026-04-30
NCT05166161A Long-Term Safety Study of PTC923 in Participants With PhenylketonuriaRECRUITING2026-04-30PHASE32022-02-142026-04-30
NCT06639451A Prospective, Multi-center Study to Evaluate Efficacy and Safety of BSJ020R in Treatment of AVF for Hemodialysis (RANGER AV Japan Study)RECRUITING2026-04-30NA2024-12-132026-12-31
NCT05153317Evaluation of Long-term Safety and Efficacy of ELX/TEZ/IVA in Cystic Fibrosis (CF) Participants 2 Years and OlderACTIVE_NOT_RECRUITING2026-04-30PHASE32022-01-172026-04-30
NCT05085366A Study to Evaluate the Efficacy, Safety, and Immunogenicity of mRNA-1647 Cytomegalovirus (CMV) Vaccine in Healthy Participants 16 to 40 Years of AgeACTIVE_NOT_RECRUITING2026-04-30PHASE32021-10-262028-04-30
NCT07024823A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD4248 in Healthy Participants and Participants With Chronic Kidney Disease and Type 2 Diabetes and to Assess Home Measurements of Creatinine in a Non Interventional CohortRECRUITING2026-04-30PHASE12025-06-092026-04-30
NCT05060016A Phase 2 Study of Tarlatamab in Patients With Small Cell Lung Cancer (SCLC)ACTIVE_NOT_RECRUITING2026-04-30PHASE22021-12-012027-04-30
NCT06676072A Study of the TactiFlex SE Catheter and Volt PFA Generator in Subjects With PAF:RECRUITING2026-04-30NA2024-11-222026-04-30
NCT06510777PICO Venous Leg Ulcers (VLU) Reimbursement StudySUSPENDED2026-04-30NA2023-12-292026-04-30
NCT05147220Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS)RECRUITING2026-04-30PHASE32021-12-162030-10-30
NCT06602193Safety and Pharmacodynamic Effects of BIIB122 in Participants With LRRK2-Associated Parkinson's Disease (LRRK2-PD)RECRUITING2026-04-30PHASE22024-10-242028-02-28
NCT06890923Nasal Foralumab in Patients With Non-Active Secondary Progressive Multiple SclerosisRECRUITING2026-04-30PHASE22025-03-042026-08-30
NCT05245500Phase 1 Study of MRTX1719 in Solid Tumors With MTAP DeletionRECRUITING2026-04-30PHASE12022-06-092026-04-30
NCT06223958Study to Evaluate the Efficacy and Safety of Intravitreal OTX-TKI (Ocular Therapeutix) (Axitinib Implant) in Subjects With Neovascular Age-Related Macular DegenerationACTIVE_NOT_RECRUITING2026-04-29PHASE32024-01-292027-09-27
NCT06422689Combination Short-Acting BroNchodilator and Inhaled Corticosteroid Rescue Therapy on Health Outcomes in Routine CareRECRUITING2026-04-29PHASE42024-05-102026-04-29
NCT03682068Study of Durvalumab Given With Chemotherapy, Durvalumab in Combination With Tremelimumab Given With Chemotherapy, or Chemotherapy in Patients With Unresectable Urothelial CancerACTIVE_NOT_RECRUITING2026-04-29PHASE32018-09-272026-04-29
NCT07168356A Study to Evaluate Blood Levels of Bepirovirsen in Adult Participants With Severe or Moderate Kidney DiseaseNOT_YET_RECRUITING2026-04-28PHASE12025-09-162026-08-18
NCT05488314A Study of Amivantamab and Capmatinib Combination Therapy in Unresectable Metastatic Non-small Cell Lung CancerACTIVE_NOT_RECRUITING2026-04-27PHASE1, PHASE22022-12-132026-04-27
NCT06213506A Study on the Safety, Reactogenicity, and Immune Response to the GVGH iNTS-GMMA Vaccine Against Invasive Nontyphoidal Salmonella in Adults, Children, and InfantsRECRUITING2026-04-27PHASE22024-01-152026-04-27
NCT05653349Study of Ianalumab Versus Placebo in Addition to First-line Corticosteroids in Primary Immune Thrombocytopenia (ITP)ACTIVE_NOT_RECRUITING2026-04-24PHASE32023-03-062028-12-18
NCT06208150A Study Comparing Talquetamab Plus Pomalidomide, Talquetamab Plus Teclistamab, and Elotuzumab, Pomalidomide, and Dexamethasone or Pomalidomide, Bortezomib, and Dexamethasone in Participants With Relapsed or Refractory Myeloma Who Have Received an Anti-CD38 Antibody and LenalidomideRECRUITING2026-04-23PHASE32024-01-222027-06-27
NCT06154447Evaluation of VX-828 in Healthy Participants and in Participants With Cystic FibrosisRECRUITING2026-04-23PHASE12023-12-122026-04-23
NCT04696809A Study of Teclistamab in Japanese Participants With Relapsed or Refractory Multiple MyelomaACTIVE_NOT_RECRUITING2026-04-22PHASE1, PHASE22021-02-222026-04-22
NCT05675449A Clinical Trial of Four Medicines (Elranatamab Plus Carfilzomib and Dexamethasone or Maplirpacept) in People With Relapsed Refractory Multiple MyelomaRECRUITING2026-04-22PHASE12022-12-142028-02-29
NCT06589713Effect of Renal Impairment on Enpatoran PharmacokineticsRECRUITING2026-04-22PHASE12024-09-242026-04-22
NCT06388187A Research Study to See How Well Different Doses of CagriSema Help People With Excess Body Weight Lose WeightACTIVE_NOT_RECRUITING2026-04-21PHASE32024-06-242026-04-21
NCT05849844Tympanoseal Clinical StudyRECRUITING2026-04-20NA2024-01-052026-04-20
NCT04305054Substudy 02B: Safety and Efficacy of Pembrolizumab in Combination With Investigational Agents or Pembrolizumab Alone in Participants With First Line (1L) Advanced Melanoma (MK-3475-02B/KEYMAKER-U02)ACTIVE_NOT_RECRUITING2026-04-20PHASE1, PHASE22020-07-012026-04-20
NCT06672523A Study to Evaluate the Mass Balance, Metabolism, Elimination, and Drug Levels of [14C]-BMS-986504 (MRTX1719) in Participants With Advanced Solid Tumors With Homozygous Methylthioadenosine Phosphorylase DeletionRECRUITING2026-04-20PHASE12025-03-242026-04-20
NCT05712356A Study of LSTA1 When Added to Standard of Care Versus Standard of Care Alone in Patients With Advanced Solid TumorsACTIVE_NOT_RECRUITING2026-04-18PHASE22023-08-242030-03
NCT06705140A Study on the Immunogenicity and Safety of 3 Different Dose Concentrations of a Respiratory Syncytial Virus Vaccine in Infants and ToddlersACTIVE_NOT_RECRUITING2026-04-17PHASE32024-11-252026-04-17
NCT01905813Study of INCB040093 in Subjects With Previously Treated B-Cell MalignanciesACTIVE_NOT_RECRUITING2026-04-17PHASE12013-06-302026-04-17
NCT07079670Safety and Immunogenicity of NVX-CoV2705NOT_YET_RECRUITING2026-04-16PHASE32025-10-162026-06-16
NCT05891249A Study to Evaluate the Safety and Effectiveness of Luspatercept for the Treatment of Transfusion-dependent (TD) Anemia Associated With Myelodysplastic Syndromes (MDS) & Beta-thalassemia (β-Thal) in IndiaACTIVE_NOT_RECRUITING2026-04-16PHASE42023-06-052026-04-16
NCT06744205A Study on the Safety and Immunogenicity of Hexavalent Influenza mRNA Vaccine in Adult Participants 50 Years of Age and OlderACTIVE_NOT_RECRUITING2026-04-16PHASE1, PHASE22025-01-062026-04-16
NCT06500884A Study to Evaluate Preventive Treatments for Talquetamab-related Oral ToxicityRECRUITING2026-04-15PHASE22024-08-262027-10-18
NCT07117487A Study of mRNA-1345 Following a Primary Dose of a Licensed Protein Subunit Respiratory Syncytial Virus (RSV) Vaccine in Adult Participants ≥60 Years of AgeRECRUITING2026-04-15PHASE32025-08-052026-04-15
NCT04463771Safety and Efficacy of Retifanlimab (INCMGA00012) Alone or in Combination With Other Therapies in Participants With Advanced or Metastatic Endometrial Cancer Who Have Progressed on or After Platinum-based Chemotherapy.ACTIVE_NOT_RECRUITING2026-04-14PHASE22021-01-262026-07-10
NCT05905341Study of PF-07224826, as a Single Agent or in Combination With Endocrine Therapy in Participants With Breast Cancer and Other Advanced Solid Tumors.WITHDRAWN2026-04-14PHASE12024-01-152028-04-13
NCT05992935Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1403 and mRNA-1405 to Prevent Norovirus Acute Gastroenteritis in Healthy Adults 18 to 80 Years of AgeACTIVE_NOT_RECRUITING2026-04-14PHASE1, PHASE22023-08-252026-11-20
NCT06573281A Study on the Safety and Immune Response to an mRNA-based RSV Investigational Vaccine in Healthy Adults Aged 18-45 YearsACTIVE_NOT_RECRUITING2026-04-13PHASE12024-09-302026-04-13
NCT05217446A Study of Encorafenib Plus Cetuximab Taken Together With Pembrolizumab Compared to Pembrolizumab Alone in People With Previously Untreated Metastatic Colorectal CancerACTIVE_NOT_RECRUITING2026-04-12PHASE22022-07-112027-01-26
NCT06013995A Study to Investigate the Safety, Tolerability, Drug Levels and Drug Effects of BMS-986326 in Adult Participants With Different Forms of LupusRECRUITING2026-04-12PHASE12023-09-212026-04-12
NCT06104449A Study of Opevesostat (MK-568)4 in Japanese Participants With Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-5684-005)ACTIVE_NOT_RECRUITING2026-04-12PHASE12023-11-142026-04-12
NCT02393625Study of Safety and Efficacy of Ceritinib in Combination With Nivolumab in Patients With ALK-positive Non-small Cell Lung CancerACTIVE_NOT_RECRUITING2026-04-09PHASE12015-05-272026-04-09
NCT06741657A Study to Find Out How Litifilimab is Processed in the Body in Healthy Participants When Given Under the Skin in 3 Different WaysRECRUITING2026-04-08PHASE12025-01-022026-04-08
NCT05612035Frespaciguat (MK-5475) INSIGNIA-PH-COPD: A Study of the Efficacy and Safety of Frespaciguat (an Inhaled sGC Stimulator) in Adults With PH-COPDACTIVE_NOT_RECRUITING2026-04-07PHASE22023-03-162029-10-07
NCT07004322A Research Study of the New Medicine NNC0519-0130 in Male Chinese Participants Living With Excess Body WeightRECRUITING2026-04-07PHASE12025-05-262026-04-07
NCT07042945MK-4646 Multiple Dose Trial in Participants With Human Immunodeficiency Virus Type 1 (HIV-1) (MK-4646-003)RECRUITING2026-04-06PHASE12025-07-092026-04-06
NCT03319667A Study to Investigate the Clinical Benefit of Isatuximab in Combination With Bortezomib, Lenalidomide and Dexamethasone in Adults With Newly Diagnosed Multiple Myeloma Not Eligible for TransplantACTIVE_NOT_RECRUITING2026-04-05PHASE32017-12-072027-06-30
NCT06716424A Study to Investigate Safety and Efficacy of iGlarLixi in Adult Patients With Type 2 Diabetes MellitusRECRUITING2026-04-03PHASE42025-01-062026-04-03
NCT06695130Study of a Combination Vaccine Comprised of Different Recombinant Spike Antigen Levels of a Matrix-M Adjuvanted Recombinant COVID-19 Vaccine and Recombinant Influenza Vaccine in Adult Participants 50 Years of Age and OlderACTIVE_NOT_RECRUITING2026-04-03PHASE1, PHASE22024-11-182026-04-03
NCT05358249Platform Study of JDQ443 in Combinations in Patients With Advanced Solid Tumors Harboring the KRAS G12C MutationACTIVE_NOT_RECRUITING2026-04-03PHASE1, PHASE22022-10-242026-05-18
NCT06622070A Study of SPY002-072 in Healthy VolunteersRECRUITING2026-04-03PHASE12024-11-182026-08-08
NCT05253651A Study of Tucatinib With Trastuzumab and mFOLFOX6 Versus Standard of Care Treatment in First-line HER2+ Metastatic Colorectal CancerRECRUITING2026-04-03PHASE32022-10-242029-07-27
NCT0567745124 Weeks Double-blind Randomized Placebo-controlled Trial to Evaluate Efficacy, PK, Safety of LOU064 in Adolescents (12 - <18) With CSU and Inadequate Response to H1-antihistamine Followed by Optional 3 Years Open-label Extension and an Optional 3 Years Safety Long-term Treatment-free Follow-upRECRUITING2026-04-02PHASE32023-07-112032-03-30
NCT06695117Study of a Combination Vaccine Comprised of Different Recombinant Spike Antigen Levels of a Matrix-M Adjuvanted Recombinant COVID-19 Vaccine and High-Dose Inactivated Influenza Vaccine in Adult Participants 50 Years of Age and OlderACTIVE_NOT_RECRUITING2026-04-01PHASE1, PHASE22024-11-192026-04-01
NCT02991469A Repeated Dose-finding Study of Sarilumab in Children and Adolescents With Systemic Juvenile Idiopathic Arthritis (SKYPS)RECRUITING2026-04-01PHASE22018-08-092029-02-19
NCT06122662AMX0035 and Progressive Supranuclear PalsyACTIVE_NOT_RECRUITING2026-04-01PHASE2, PHASE32023-12-212029-11-30
NCT04278768Dose Escalation/ Expansion Study of CA-4948 as Monotherapy in Patients With Acute Myelogenous Leukemia (AML) or Myelodysplastic Syndrome (MDS)RECRUITING2026-04-01PHASE1, PHASE22020-07-062026-04-01
NCT06033586Study to Evaluate the Long-term Safety of Rusfertide (PTG-300) in Subjects With Polycythemia VeraACTIVE_NOT_RECRUITING2026-04-01PHASE32024-01-222027-04-01
NCT06961266A Study to Investigate Efficacy, Safety, Tolerability, and Pharmacokinetics of JZP441 Compared With Placebo in Participants With Narcolepsy Type 1RECRUITING2026-04-01PHASE12025-05-132026-04-01
NCT06625398An Efficacy, Safety, and Tolerability Study of VRDN-003 in Participants With Chronic Thyroid Eye Disease (TED)ACTIVE_NOT_RECRUITING2026-04-01PHASE32024-08-272026-12-15
NCT05429268Study to Evaluate the Safety and Efficacy of Tafasitamab Plus Lenalidomide in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (firmMIND)ACTIVE_NOT_RECRUITING2026-04-01PHASE32022-12-232027-04-01
NCT06162728Dose Escalation Trial of Safety, Pharmacokinetic/Pharmacodynamic and Preliminary Clinical Activity of Briquilimab in Adult Patients with Chronic Spontaneous Urticaria (CSU)RECRUITING2026-04-01PHASE1, PHASE22023-11-292026-04-01
NCT06144684A Two-Part First-In-Human Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GUB014295RECRUITING2026-04PHASE12023-11-292026-04
NCT05818150GAE Using Embosphere Microspheres vs Corticosteroid Injections for Treatment of Symptomatic Knee OA (MOTION)RECRUITING2026-04NA2024-01-162027-10
NCT04379050Extension Study To Evaluate Safety And Tolerability Of 24-Hour Daily Exposure Of Continuous Subcutaneous Infusion of ABBV-951 In Adult Participants With Parkinson's DiseaseACTIVE_NOT_RECRUITING2026-04PHASE32020-06-082026-04
NCT04785196APG-115 in Combination With PD-1 Inhibitor in Patients With Advanced Liposarcoma or Advanced Solid TumorsRECRUITING2026-04PHASE1, PHASE22021-05-262027-01
NCT04750226Study To Assess Adverse Events and Change in Disease Activity Of 24-hour Continuous Subcutaneous Infusion Of ABBV-951 In Adult Participants With Advanced Parkinson's DiseaseACTIVE_NOT_RECRUITING2026-04PHASE32021-02-182026-04
NCT06588491KYSA-8: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell (CD-19 CAR T) Therapy, in Subject With Treatment Refractory Stiff Person SyndromeRECRUITING2026-04PHASE22024-09-252026-12
NCT06794866A Study to Assess Adverse Events and Effectiveness of OnabotulinumtoxinA Intramuscular Injections for the Change of Moderate to Severe Forehead Lines in Adult ParticipantsACTIVE_NOT_RECRUITING2026-04PHASE32025-01-222026-04
NCT04965493A Trial of Pirtobrutinib (LOXO-305) Plus Venetoclax and Rituximab (PVR) Versus Venetoclax and Rituximab (VR) in Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)ACTIVE_NOT_RECRUITING2026-04PHASE32021-09-202027-01
NCT04198870MitraClip REPAIR MR StudyRECRUITING2026-04NA2020-07-212034-04
NCT06683508A Study to Investigate Weight Management With LY3549492 Compared With Placebo in Adult Participants With Obesity or OverweightACTIVE_NOT_RECRUITING2026-04PHASE22024-11-132026-09
NCT06977568A Study to Evaluate an Intra-Articular Injection of ZILRETTA Versus Triamcinolone Acetonide, Immediate Release in Subjects With Osteoarthritis of the HipRECRUITING2026-04PHASE22025-07-252026-04
NCT07030127A Study of LY3985863 in Healthy ParticipantsRECRUITING2026-04PHASE12025-08-112026-04
NCT06161571A Study Evaluating Efruxifermin in Subjects With Non-invasively Diagnosed Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Nonalcoholic Fatty Liver Disease (NAFLD)/Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)ACTIVE_NOT_RECRUITING2026-04PHASE32023-11-102026-10
NCT06615557Fasedienol Nasal Spray for the Acute Treatment of Anxiety in Adults With Social Anxiety Disorder (PALISADE-4)RECRUITING2026-04PHASE32024-09-162026-10
NCT06337084Diagnostic Efficacy and Dosimetry of MNPR-101-DFO*-89Zr in Patients With Solid TumorsRECRUITING2026-04PHASE12024-05-302026-04
NCT05329584InSpace Accelerated Rehabilitation StudyRECRUITING2026-04NA2022-02-072026-12
NCT06235983A Study of LY3537982 in Chinese Participants With Advanced Solid TumorsACTIVE_NOT_RECRUITING2026-04PHASE12024-02-292027-04
NCT07011537Examining the Impact of a Digital Health Program and TENS Device for Patients With Chronic Low Back PainNOT_YET_RECRUITING2026-04NA2025-102026-10
NCT07090655A Phase 1 Study of Budoprutug (TNT119) Subcutaneous and Intravenous Injections in Normal Healthy VolunteersRECRUITING2026-04EARLY_PHASE12025-08-112026-06
NCT06029972Study of Tilpisertib Fosmecarbil in Participants With Moderately to Severely Active Ulcerative ColitisRECRUITING2026-04PHASE22023-12-052027-05
NCT06630299Study to Compare an Oral Weekly Islatravir/Lenacapavir Regimen With Standard of Care in Virologically Suppressed People With HIV-1ACTIVE_NOT_RECRUITING2026-04PHASE32024-10-082030-08
NCT05892614Study to Evaluate the Efficacy, Safety, and Tolerability of Efzofitimod in Patients With Systemic Sclerosis (SSc)-Related Interstitial Lung Disease (ILD) (SSc-ILD)RECRUITING2026-04PHASE22023-10-262026-04
NCT06979544A Study to Assess the Safety and Efficacy of Oral LPCN 1154A in Women With Severe PPDRECRUITING2026-04PHASE32025-06-162026-05
NCT04136171CARDIO-TTRansform: A Study to Evaluate the Efficacy and Safety of Eplontersen (Formerly Known as ION-682884, IONIS-TTR-LRx and AKCEA-TTR-LRx) in Participants With Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR CM)ACTIVE_NOT_RECRUITING2026-04PHASE32020-03-132026-08
NCT06202339Alpha Radiation Emitters Device for the Treatment of Primary and Recurrent Squamous Cell Carcinoma of the Vulva (DaRT).NOT_YET_RECRUITING2026-04NA2024-042026-12
NCT07141199A Study to Evaluate Adverse Events, How the Drug is Tolerated, and How the Drug Moves Through the Body of Intravenous Infusions of ABBV-8736 in Adult Healthy VolunteersRECRUITING2026-04PHASE12025-09-022026-04
NCT06673238A Study to Assess How the Drug Moves Through the Body, Adverse Events, and Tolerability of Oral ABBV-722 Capsules of Single and Multiple Ascending Doses in Adult Participants and Single Doses in Adult Asian ParticipantsRECRUITING2026-04PHASE12024-10-292026-04
NCT06312189Long-term Study to Evaluate Safety and Tolerability of Valbenazine in Participants With Chorea Associated With Huntington Disease in CanadaENROLLING_BY_INVITATION2026-04PHASE32024-04-242026-04
NCT06945419A Study of LY4086940 in Healthy Participants and Participants With Overweight or Obesity, With or Without Type 2 DiabetesRECRUITING2026-04PHASE12025-04-232026-04
NCT05074420A Study of Baricitinib (LY3009104) in Children With COVID-19RECRUITING2026-04PHASE32021-12-212026-05
NCT06797375Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of RLYB116 in Healthy ParticipantsRECRUITING2026-04PHASE12025-04-142026-06
NCT06630286Study to Compare an Oral Weekly Islatravir/Lenacapavir Regimen With Bictegravir/Emtricitabine/Tenofovir Alafenamide in Virologically Suppressed People With HIV-1ACTIVE_NOT_RECRUITING2026-04PHASE32024-10-092030-08
NCT06897202A Study to Evaluate the Efficacy and Safety of Once-Weekly MET097 in Adults With Obesity or Overweight and T2DMRECRUITING2026-04PHASE22025-03-142026-06
NCT06650761A Phase I Study of CDX-622RECRUITING2026-04PHASE12024-11-012026-04
NCT06634420HAELO: A Phase 3 Study to Evaluate NTLA-2002 in Participants With Hereditary Angioedema (HAE)ACTIVE_NOT_RECRUITING2026-04PHASE32025-01-152027-09
NCT06809179A Clinical Trial to Assess the Efficacy, Safety, and Tolerability of a Repeat Dose of Fasedienol Nasal Spray for the Acute Treatment of Anxiety in Adults With Social Anxiety DisorderRECRUITING2026-04PHASE22025-01-092026-12
NCT06588296Ixekizumab Concomitantly Administered With Tirzepatide in Adults With Psoriatic Arthritis and Obesity or OverweightACTIVE_NOT_RECRUITING2026-04PHASE32024-09-242026-08
NCT06635057A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes During RamadanRECRUITING2026-04PHASE42024-10-112026-04
NCT05302063A Study to Evaluate the Effect of Spinal Cord Stimulation (SCS) on Painful Diabetic Peripheral Neuropathy (pDPN)ACTIVE_NOT_RECRUITING2026-04NA2022-09-222026-04
NCT06556368A Study to Evaluate the Efficacy and Safety of Tarcocimab Tedromer and Tabirafusp Tedromer Compared to Aflibercept in Participants With Neovascular (Wet) Age-related Macular Degeneration (wAMD) - DAYBREAKRECRUITING2026-04PHASE32024-08-232027-04
NCT06834165Study Evaluating the Safety and Efficacy of Neffy or Intramuscular Adrenalin in Patients with Allergic Reactions After Oral Food Challenge or Allergen ImmunotherapyNOT_YET_RECRUITING2026-04PHASE42025-04-302026-06
NCT06982508Evaluation of Obicetrapib on Antioxidant Levels in Plasma and HDL Particles of Healthy VolunteersNOT_YET_RECRUITING2026-04PHASE22025-082026-06
NCT05929066A Study of Retatrutide (LY3437943) in Participants Who Have Obesity or OverweightACTIVE_NOT_RECRUITING2026-04PHASE32023-07-102026-05
NCT06643728A Study to Investigate Weight Management With Bimagrumab (LY3985863) and Tirzepatide (LY3298176), Alone or in Combination, in Adults With Obesity or OverweightACTIVE_NOT_RECRUITING2026-04PHASE22024-10-212027-01
NCT05980806A Study of Selinexor Monotherapy in Subjects with JAK Inhibitor-naĂŻve Myelofibrosis and Moderate ThrombocytopeniaRECRUITING2026-04PHASE22024-04-222028-10
NCT07006792A Study to See How Well Lebrikizumab Works in Adults and Adolescents With Moderate Atopic Dermatitis (Eczema) and High Itch BurdenRECRUITING2026-04PHASE42025-06-162026-09
NCT06032416DenCT Shoulder Bone Quality EvaluationNOT_YET_RECRUITING2026-04NA2025-042027-04
NCT04088396A Study of Baricitinib (LY3009104) in Participants From 1 Year to Less Than 18 Years Old With Systemic Juvenile Idiopathic Arthritis (sJIA)RECRUITING2026-04PHASE32020-02-122026-05
NCT06182969A Study of APG-2575 in Patients with Mild-to-moderate Systemic Lupus Erythematosus.RECRUITING2026-04PHASE1, PHASE22024-08-092026-12
NCT05882045A Study of Retatrutide (LY3437943) in Participants With Obesity and Cardiovascular DiseaseACTIVE_NOT_RECRUITING2026-04PHASE32023-05-302026-05
NCT06774131A Phase 3 Single-arm Study of UGN-104 for the Treatment of Low-grade Upper Tract Urothelial CancerRECRUITING2026-03-31PHASE32025-05-022027-03-31
NCT05648591Safety and Tolerability of Open-Labeled Iloperidone in AdolescentsRECRUITING2026-03-31PHASE42023-05-242026-11-30
NCT03984097A Study to Evaluate Subcutaneous TAK-079 Added to Standard of Care Regimens in Participants With Newly Diagnosed Multiple Myeloma (NDMM)ACTIVE_NOT_RECRUITING2026-03-31PHASE12019-07-292026-03-31
NCT04094311Study of Out of Specification for TisagenlecleucelRECRUITING2026-03-31PHASE32019-11-212026-03-31
NCT06909773The Prevalence, Disease Burden and Prognosis of COPD in Patients With Cardiovascular DiseasesNOT_YET_RECRUITING2026-03-31NA2025-09-302026-06-30
NCT05199701Prospective Case Collection Study for New Mammography TechnologiesRECRUITING2026-03-31NA2021-12-102026-03-31
NCT06831370A Study of Brentuximab Vedotin With Doxorubicin, Vinblastine and Dacarbazine in Adults With Hodgkin Lymphoma in IndiaRECRUITING2026-03-31PHASE42024-08-282026-03-31
NCT03786081Safety and Efficacy of Tisotumab Vedotin Monotherapy & in Combination With Other Cancer Agents in Subjects With Cervical CancerACTIVE_NOT_RECRUITING2026-03-31PHASE1, PHASE22019-02-272026-03-31
NCT06643884Suprachoroidal Administration in Subjects With Metastases to the ChoroidRECRUITING2026-03-31PHASE22024-12-162027-02-28
NCT04420884A Study of Dazostinag as Single Agent and Dazostinag in Combination With Pembrolizumab in Adults With Advanced or Metastatic Solid TumorsACTIVE_NOT_RECRUITING2026-03-31PHASE1, PHASE22020-07-222026-03-31
NCT06357832New Investigational Stimulation Protocol for Treatment of Major Depression Disorder (MDD)ACTIVE_NOT_RECRUITING2026-03-31NA2024-04-292026-04-30
NCT05303467A Feasibility Study to Evaluate the Safety of the TheraSphere Glioblastoma (GBM) Device in Patients With Recurrent GBMRECRUITING2026-03-31PHASE12022-07-302026-06-01
NCT04634552A Study of Talquetamab in Participants With Relapsed or Refractory Multiple MyelomaRECRUITING2026-03-31PHASE22021-02-012029-03-30
NCT02932618A Study of Recombinant Von Willebrand Factor (rVWF) With or Without ADVATE in Children With Severe Von Willebrand Disease (VWD)RECRUITING2026-03-31PHASE32017-11-062026-03-31
NCT05048797A Study to Investigate the Efficacy and Safety of Trastuzumab Deruxtecan as the First Treatment Option for Unresectable, Locally Advanced/Metastatic Non-Small Cell Lung Cancer With HER2 MutationsRECRUITING2026-03-31PHASE32021-10-282027-07-30
NCT05939414An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Observation in PSMA Positive OMPC.RECRUITING2026-03-31PHASE32024-03-122031-10-03
NCT06451614SpaceIT Hydrogel System for Perirectal SpacingRECRUITING2026-03-31NA2024-10-302028-03-31
NCT06267560Lp(a) Lowering Study of Pelacarsen (TQJ230) in US Black/African American and Hispanic Participants With Elevated Lp(a) and Established ASCVDACTIVE_NOT_RECRUITING2026-03-31PHASE32024-04-242026-03-31
NCT04553133PF-07104091 as a Single Agent and in Combination TherapyACTIVE_NOT_RECRUITING2026-03-30PHASE22020-09-162026-03-30
NCT05976243A Study to Investigate Efficacy, Safety, and Tolerability of Remibrutinib Compared With Placebo in Adults With CINDU Inadequately Controlled by H1-antihistaminesRECRUITING2026-03-30PHASE32023-12-072028-12-31
NCT03175224APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid TumorsRECRUITING2026-03-30PHASE22017-09-272026-11-30
NCT05543681Clinical Trial on Agitation in Alzheimer's DementiaRECRUITING2026-03-30PHASE22022-10-112026-03-30
NCT04779918Ventral or Inguinal Hernia, Robotically Repaired With OviTex MeshRECRUITING2026-03-30NA2021-04-292027-12-30
NCT06115967A Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics of Subcutaneous AZD6912 in Healthy ParticipantsACTIVE_NOT_RECRUITING2026-03-30PHASE12023-11-152026-03-30
NCT06934226A Study to Assess Efficacy and Safety of JNJ-77242113 Compared to Placebo and Ustekinumab in Participants With Moderate to Severe Plaque PsoriasisACTIVE_NOT_RECRUITING2026-03-30PHASE32025-04-152027-08-20
NCT06334991Study for Subjects with Relapsed/Refractory Non-Hodgkin LymphomaRECRUITING2026-03-30PHASE12024-08-232027-03-30
NCT03401788A Phase 2 Study of Belzutifan (PT2977, MK-6482) for the Treatment of Von Hippel Lindau (VHL) Disease-Associated Renal Cell Carcinoma (RCC) (MK-6482-004)ACTIVE_NOT_RECRUITING2026-03-29PHASE22018-05-022026-03-29
NCT04895696A Study Evaluating the Efficacy and Safety of Afimetoran Compared With Placebo in Participants With Active Systemic Lupus Erythematosus (SLE)ACTIVE_NOT_RECRUITING2026-03-29PHASE22021-10-112029-04-22
NCT06430866Pharmacokinetic Similarity Between ABP 234 and Keytruda® (Pembrolizumab)RECRUITING2026-03-27PHASE32024-09-122027-03-15
NCT06768671An Open-label, Single-arm Study to Evaluate Pharmacokinetics and Safety of Subcutaneous Sonelokimab in Adolescents With Moderate to Severe Hidradenitis Suppurativa (VELA-TEEN)RECRUITING2026-03-27PHASE32024-12-302026-03-27
NCT04817618Study of Efficacy and Safety of Iptacopan in Patients With C3 Glomerulopathy.RECRUITING2026-03-27PHASE32021-07-282026-07-04
NCT05180474GEN1047 for Solid Tumors - First in Human (FIH) TrialACTIVE_NOT_RECRUITING2026-03-26PHASE1, PHASE22021-12-132026-03-26
NCT06057038A Safety Trial of GEN1042 in Japanese Subjects With Malignant Solid TumorsACTIVE_NOT_RECRUITING2026-03-26PHASE12023-11-242026-12-26
NCT06719011A Study on How NNC0174-1213 Works in People With Overweight or Obesity.RECRUITING2026-03-26PHASE12024-12-032026-05-17
NCT05864846A Study to Investigate Behavioral and Other Co-Occurring Outcomes With Epidiolex as Add-On Therapy in Participants Aged 1 to 65 Years of Age With Tuberous Sclerosis ComplexACTIVE_NOT_RECRUITING2026-03-26PHASE42023-06-292026-03-26
NCT07146750A Bioequivalence Study of Amlitelimab Delivered by 2 Different Devices in Healthy Adult ParticipantsRECRUITING2026-03-25PHASE12025-08-252026-04-08
NCT06942936A Study to Investigate the Impact of Multiple Doses of Itraconazole on AZD5004 in Healthy Participants and Multiple Doses of AZD5004 on Combined Oral Ethinyl Oestradiol and Levonorgestrel in Healthy Female ParticipantsRECRUITING2026-03-25PHASE12025-05-282026-03-25
NCT06280391A Proof-of-Concept Study to Assess the Efficacy, Safety and Tolerability of Itepekimab (Anti-IL-33 mAb) in Participants With Non-cystic Fibrosis BronchiectasisACTIVE_NOT_RECRUITING2026-03-24PHASE22024-02-202026-08-11
NCT05818553A Clinical Trial of PRAX-562 in Subjects With Developmental and Epileptic Encephalopathies (DEE)RECRUITING2026-03-23PHASE2, PHASE32023-08-022027-03-01
NCT06952699A Study of TAK-360 in Adults With Narcolepsy Without Cataplexy (NT2)RECRUITING2026-03-23PHASE22025-05-062026-04-23
NCT06102005Dose Ranging Study of Lunsekimig Compared With Placebo-control in Adult Participants With Moderate-to-severe AsthmaACTIVE_NOT_RECRUITING2026-03-23PHASE22023-10-162026-03-23
NCT05174221A Study of Mezagitamab in Adults With Primary Immunoglobulin A Nephropathy Receiving Stable Background TherapyACTIVE_NOT_RECRUITING2026-03-23PHASE12022-11-092026-03-23
NCT05583526A 52-Week Study of Ritlecitinib Oral Capsules in Adults and Adolescents With Nonsegmental Vitiligo (Active and Stable) TranquilloACTIVE_NOT_RECRUITING2026-03-22PHASE32022-12-012026-03-22
NCT03557619A Study to Assess the Effect of Venetoclax on Ethinyl Estradiol and Levonorgestrel in Female Participants With Different Hematological MalignanciesRECRUITING2026-03-21PHASE12019-07-302026-03-21
NCT06887933A Trial to Evaluate the Safety of Niraparib Tablets in Adult Female Participants With Advanced or Relapsed Epithelial Ovarian CancerNOT_YET_RECRUITING2026-03-20PHASE42025-04-222026-07-08
NCT03460977Mevrometostat Treatment of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular LymphomaRECRUITING2026-03-19PHASE12018-04-172026-03-19
NCT05776927A Study to Evaluate the Efficacy and Safety of QVM149 (Indacaterol Acetate / Glycopyrronium Bromide / Mometasone Furoate) Versus Salmeterol Xinafoate/Fluticasone Propionate in Children From 12 Years to Less Than 18 Years of Age With Asthma.NOT_YET_RECRUITING2026-03-18PHASE32026-02-012029-02-01
NCT06529419A Dose Range-Finding Study to Assess the Efficacy and Safety of Multiple Dose Levels of AZD8630 in Adults With Uncontrolled Asthma at Risk of ExacerbationsRECRUITING2026-03-18PHASE22024-08-302026-04-06
NCT04585750The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)RECRUITING2026-03-17PHASE1, PHASE22020-10-292026-07-14
NCT06113471A Study to Evaluate Efficacy and Safety of Povorcitinib in Participants With Nonsegmental Vitiligo (STOP-V2)ACTIVE_NOT_RECRUITING2026-03-17PHASE32023-11-272027-03-16
NCT03997123Capivasertib+Paclitaxel as First Line Treatment for Patients With Locally Advanced or Metastatic TNBCACTIVE_NOT_RECRUITING2026-03-16PHASE32019-06-252026-03-16
NCT06830863A Study to Evaluate Topical ATR04-484 for EGFRi-Associated Dermal ToxicityRECRUITING2026-03-15PHASE1, PHASE22025-08-252026-05-15
NCT05609812Atacicept in Subjects With Active Lupus Nephritis (COMPASS)WITHDRAWN2026-03-15PHASE32022-11-022028-12-15
NCT05618925Study for Subjects With Relapsed/Refractory Non- Hodgkin LymphomaRECRUITING2026-03-15PHASE12024-11-012027-03-15
NCT06710795AFFIX: Post-market Study of MaxTack™ Motorized Fixation Device in Subjects Undergoing Ventral Hernia RepairRECRUITING2026-03-15NA2024-11-262027-02-15
NCT05649722An Extension Study of Treprostinil Palmitil Inhalation Powder (TPIP) for Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)ACTIVE_NOT_RECRUITING2026-03-14PHASE2, PHASE32023-05-112026-03-14
NCT07082426Early System Experience With the Abbott Balloon-expandable TAVI System: First-In-Human StudyACTIVE_NOT_RECRUITING2026-03-13NA2024-11-212026-05-30
NCT06308263Tuvusertib (M1774) Human Mass Balance and Absolute Bioavailability Study (DDRIVER Solid Tumors 303)RECRUITING2026-03-13PHASE12024-03-252026-03-13
NCT06012435A Study of SGN-B6A Versus Docetaxel in Previously Treated Non-small Cell Lung CancerACTIVE_NOT_RECRUITING2026-03-12PHASE32024-02-212028-03-11
NCT04225156A Long-term Study to Assess the Safety and Efficacy of Efgartigimod in Adult Patients With Primary Immune Thrombocytopenia (ITP).ACTIVE_NOT_RECRUITING2026-03-11PHASE32020-06-022026-03-11
NCT06134648Study of a Respiratory Syncytial Virus/Human Metapneumovirus Vaccine CandidateACTIVE_NOT_RECRUITING2026-03-10PHASE1, PHASE22023-11-012026-03-10
NCT03333343Study of EGF816 in Combination With Selected Targeted Agents in EGFR-mutant NSCLCACTIVE_NOT_RECRUITING2026-03-09PHASE12018-01-292026-03-09
NCT07162610Efficacy and Safety of Rejuviel V in the Correction of Midface Volume DeficitACTIVE_NOT_RECRUITING2026-03-08NA2024-04-072026-03-30
NCT04895748DFF332 as a Single Agent and in Combination With Everolimus & Immuno-Oncology Agents in Advanced/Relapsed Renal Cancer & Other MalignanciesACTIVE_NOT_RECRUITING2026-03-06PHASE12021-11-302026-03-06
NCT04910776Clinical Study for Treatment-naĂŻve IOPD Babies to Evaluate Efficacy and Safety of ERT With Avalglucosidase AlfaACTIVE_NOT_RECRUITING2026-03-06PHASE32021-09-012027-08-10
NCT06295809A Study of (Neo)Adjuvant Intismeran Autogene (V940) and Pembrolizumab in Cutaneous Squamous Cell Carcinoma (V940-007)ACTIVE_NOT_RECRUITING2026-03-05PHASE2, PHASE32024-04-182026-03-05
NCT06604767Study of a Respiratory Syncytial Virus/Human Metapneumovirus/Parainfluenza Virus Type 3 Vaccine Candidate in Adults Aged 60 Years and OlderACTIVE_NOT_RECRUITING2026-03-05PHASE12024-09-172026-03-05
NCT06054113Study of Blinatumomab Administration in Chinese Pediatric Participants With Relapsed/Refractory B Precursor Acute Lymphoblastic Leukemia (R/R B-ALL)RECRUITING2026-03-04PHASE22024-07-232027-12-24
NCT05348577Study of Capivasertib + Docetaxel vs Placebo + Docetaxel as Treatment for Metastatic Castration Resistant Prostate Cancer (mCRPC)ACTIVE_NOT_RECRUITING2026-03-04PHASE32022-03-252026-03-04
NCT06132841A Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD6234 After Repeat Dose Administration in Participants Who Are Overweight or ObeseACTIVE_NOT_RECRUITING2026-03-04PHASE12023-11-132026-03-23
NCT06502366A Study to Investigate the Effect on Lung Function of BDA Formulated With a New Propellant (HFO) Compared With an Approved Asthma Treatment (BDA With HFA Propellant) in Participants With AsthmaRECRUITING2026-03-03PHASE32024-07-222026-03-03
NCT05250973A Study of Daratumumab-Based Therapies in Participants With Amyloid Light Chain (AL) AmyloidosisACTIVE_NOT_RECRUITING2026-03-03PHASE22022-03-012027-03-02
NCT04544189Study Assessing the Efficacy and Safety of Treatment With Alpelisib Plus Fulvestrant Versus Placebo Plus Fulvestrant in Chinese Men and Postmenopausal Women With Advanced Breast CancerACTIVE_NOT_RECRUITING2026-03-02PHASE22021-01-202026-03-02
NCT06040086Efficacy and Safety of Tozorakimab in Symptomatic Chronic Obstructive Pulmonary Disease With a History of ExacerbationsACTIVE_NOT_RECRUITING2026-03-02PHASE32023-09-222026-05-22
NCT03226808Vivacit-E Post-market Follow-up StudyACTIVE_NOT_RECRUITING2026-03-02NA2013-10-012028-06-30
NCT05648968A Study of Efficacy and Safety of Ianalumab in Previously Treated Patients With Warm Autoimmune Hemolytic AnemiaRECRUITING2026-03-02PHASE32022-12-302029-05-02
NCT06007690A Phase 3 Randomized, Masked, Controlled Trial to Evaluate Efficacy and Safety of Belzupacap Sarotalocan (AU-011) Treatment Compared to Sham Control in Subjects With Primary Indeterminate Lesions or Small Choroidal MelanomaRECRUITING2026-03-01PHASE32023-12-062027-03-01
NCT05866627A Study to Assess the Effect of Famotidine on the Drug Levels of Afimetoran in Healthy ParticipantsRECRUITING2026-03-01PHASE12023-07-042026-03-01
NCT05877963Study to Evaluate Safety, Efficacy and Pharmacokinetics (PK) of a Modified Regimen of UblituximabRECRUITING2026-03-01PHASE32023-06-132026-03-01
NCT05061004Cephea Early Feasibility StudyRECRUITING2026-03-01NA2022-04-282031-03-01
NCT05743270Study of RP3 in Combination With Nivolumab and Other Therapy in Patients With Locoregionally Advanced or Recurrent SCCHNWITHDRAWN2026-03-01PHASE22024-01-302026-06-01
NCT06625411An Efficacy, Safety, and Tolerability Study of VRDN-003 in Participants With Active Thyroid Eye Disease (TED)ACTIVE_NOT_RECRUITING2026-03-01PHASE32024-08-272026-11-15
NCT05548127TACTIVE-U: A Study to Learn About the Study Medicine (Vepdegestrant) When Given With Other Medicines in People With Advanced or Metastatic Breast Cancer (Sub-Study A)ACTIVE_NOT_RECRUITING2026-03-01PHASE1, PHASE22023-02-232026-03-01
NCT05639751PRT3789 Monotherapy and in Combo w/Docetaxel in Participants w/Advanced or Metastatic Solid Tumors w/SMARCA4 MutationACTIVE_NOT_RECRUITING2026-03PHASE12023-05-022026-03
NCT06517316Cosmetic Contact Lenses Post-Market Clinical Follow-up StudyWITHDRAWN2026-03NA2025-012026-03
NCT06201416Study of Single Doses of SBT777101 in Subjects With Rheumatoid ArthritisRECRUITING2026-03PHASE12024-03-062026-03
NCT05544019Study of SGR-1505 in Mature B-Cell NeoplasmsRECRUITING2026-03PHASE12023-04-102026-03
NCT06947304Evaluation of Miricorilant on Liver Fat in Patients With MASLDRECRUITING2026-03PHASE12025-08-012026-03
NCT06891703[18F]ACI-15916 PET in α-synucleinopathiesRECRUITING2026-03EARLY_PHASE12025-03-202026-03
NCT04400331Open-Label Rollover Study for Continuing Valbenazine Administration for the Treatment of Chorea Associated With Huntington DiseaseACTIVE_NOT_RECRUITING2026-03PHASE32020-09-182026-03
NCT06723171Evaluation of Safety and Efficacy of IRX4204 in Mild to Moderate Plaque PsoriasisNOT_YET_RECRUITING2026-03PHASE22025-062026-04
NCT06290934Study of GS-1427 in Participants With Moderately to Severely Active Ulcerative ColitisRECRUITING2026-03PHASE22024-03-272027-07
NCT05327959A.L.P.S. Clavicle Plating System PMCFENROLLING_BY_INVITATION2026-03NA2022-05-132027-03
NCT06079398A Clinical Trial to Evaluate Efficacy and Safety of TransCon CNP Compared With Placebo in Infants (0 to <2 Years of Age) With AchondroplasiaRECRUITING2026-03PHASE22024-01-232027-03
NCT07189013Assessing Patient Preference for Infusion SystemsNOT_YET_RECRUITING2026-03NA2025-10-152026-04
NCT06828861ARD-101 for Treatment of PWS: The Hunger Elimination or Reduction Objective TrialRECRUITING2026-03PHASE32024-12-202026-04
NCT05286229A Study to Assess Adverse Events and Change in Disease State of Intravenously (IV) Infused Etentamig (ABBV-383) of Adult Participants With Relapsed or Refractory Multiple Myeloma in JapanACTIVE_NOT_RECRUITING2026-03PHASE12022-03-242026-03
NCT06400303KYSA-5: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell (CD19 CAR T) Therapy, in Subjects With Systemic SclerosisACTIVE_NOT_RECRUITING2026-03PHASE1, PHASE22024-08-062027-03
NCT05612581A Platform Study to Evaluate Investigational Therapies in Chronic Hepatitis B InfectionACTIVE_NOT_RECRUITING2026-03PHASE1, PHASE22023-05-102027-03
NCT06343779Study of Oral Deucrictibant Soft Capsule for On-Demand Treatment of Angioedema Attacks in Adolescents and Adults With Hereditary AngioedemaRECRUITING2026-03PHASE32024-02-262026-03
NCT07016750A Study Assessing KB803 Compared to Matching Placebo for the Treatment and Prevention of Corneal Abrasions in Dystrophic Epidermolysis BullosaRECRUITING2026-03PHASE32025-06-202026-03
NCT06031415Study of GS-0272 in Participants With Rheumatoid ArthritisRECRUITING2026-03PHASE12023-09-282026-03
NCT06747468Avexitide for Treatment of Post-Bariatric HypoglycemiaRECRUITING2026-03PHASE32025-04-292026-10
NCT05803421A Study of Daily Oral Orforglipron (LY3502970) Compared With Insulin Glargine in Participants With Type 2 Diabetes and Obesity or Overweight at Increased Cardiovascular RiskACTIVE_NOT_RECRUITING2026-03PHASE32023-04-032026-03
NCT07137689A Study of LY3537982 in Participants With Kidney Problems Compared With Participants With Normal Kidney FunctionNOT_YET_RECRUITING2026-03PHASE12025-082026-03
NCT06522035Evaluation of Allocetra by Intra-articular Injection for the Treatment of Psoriatic ArthritisRECRUITING2026-03PHASE12024-08-012026-09
NCT02999009Trident II Tritanium Acetabular Shell Outcomes StudyACTIVE_NOT_RECRUITING2026-03NA2017-01-202031-03
NCT06692153Embecta AID System in Adults With Type 2 DiabetesWITHDRAWN2026-03NA2025-012026-05
NCT04401748Study Of Venetoclax Tablet With Intravenous or Subcutaneous Azacitidine to Assess Change in Disease Activity In Adult Participants With Newly Diagnosed Higher-Risk Myelodysplastic SyndromeACTIVE_NOT_RECRUITING2026-03PHASE32020-09-102026-03
NCT05924594Phase 3 Efficacy and Safety Laboratory Classroom Study in Pediatrics (6-12) With ADHD Using CTx-1301SUSPENDED2026-03PHASE32023-07-312026-03
NCT07065773Safety, Tolerability and Efficacy of Trichostatin A in Patients With Mild to Severe OnychomycosisRECRUITING2026-03PHASE22025-05-052026-05
NCT06539507A Study of the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of BCX17725RECRUITING2026-03PHASE12024-09-262026-03
NCT06347159A Study of EDG-7500 in Adults With Hypertrophic Cardiomyopathy (CIRRUS-HCM)RECRUITING2026-03PHASE22024-04-112026-03
NCT07069036A Study to Evaluate Single and Multiple Doses of SEP-631 in Healthy Adult VolunteersNOT_YET_RECRUITING2026-03PHASE12025-072026-04
NCT04868877Phase 1/2 Study Evaluating MCLA-129, a Human Anti-EGFR, Anti-c-MET Bispecific Antibody, in Advanced NSCLC and Other Solid Tumors, Alone and in CombinationRECRUITING2026-03PHASE1, PHASE22021-04-282027-03
NCT06998043Study With Phage for CF Subjects With Pseudomonas Lung InfectionRECRUITING2026-03PHASE22025-07-022026-09
NCT06340451Study to Assess the Efficacy and Safety of Iovera®° System in Subjects With Upper Extremity SpasticityRECRUITING2026-03PHASE32024-04-162026-03
NCT05684796Comparison of Two Pulmonary Embolism TreatmentsACTIVE_NOT_RECRUITING2026-03NA2023-11-272026-10
NCT06602271PF614 Analgesic Activity in Acute Postoperative Pain (PF614-301)NOT_YET_RECRUITING2026-03PHASE32025-032026-04
NCT05891171Study of AB598 Monotherapy and Combination Therapy in Participants With Advanced CancersACTIVE_NOT_RECRUITING2026-03PHASE12023-10-132026-03
NCT05144243Study to Assess Adverse Events and Change in Disease State of Oral Venetoclax in Combination With Subcutaneous (SC) Azacitidine in Newly Diagnosed Adult Participants With Acute Myeloid Leukemia (AML) Who Are Ineligible for Intensive Chemotherapy in ChinaACTIVE_NOT_RECRUITING2026-03PHASE42022-01-062026-03
NCT05768854Setrusumab vs Bisphosphonates in Pediatric Subjects With Osteogenesis ImperfectaACTIVE_NOT_RECRUITING2026-03PHASE32023-06-142027-04
NCT01679132BAROSTIM NEO Hypertension Pivotal TrialSUSPENDED2026-03NA2013-04-122026-03
NCT05226780Extension Study to Evaluate How Safe and Tolerable NBI-921352 is as an Adjunctive Therapy for Participants With SCN8A-DEEACTIVE_NOT_RECRUITING2026-03PHASE22022-07-122026-03
NCT04562389Study of Selinexor in Combination With Ruxolitinib in MyelofibrosisACTIVE_NOT_RECRUITING2026-03PHASE32021-03-112028-03
NCT06223880A Study to Evaluate the Efficacy of AXS-05 Compared to Bupropion in Preventing the Relapse of Depressive SymptomsRECRUITING2026-03PHASE42023-12-272026-03
NCT06521554A Study of NVL-330 in Patients With Advanced or Metastatic HER2-altered NSCLC (HEROEX-1)RECRUITING2026-03PHASE12024-07-182026-03
NCT06411288Global Study of Del-desiran for the Treatment of DM1ACTIVE_NOT_RECRUITING2026-03PHASE32024-05-302026-09
NCT04951219A Phase 3 Study to Evaluate Safety and Biomarkers of Resmetirom (MGL-3196) in Patients With Non-alcoholic Fatty Liver Disease (NAFLD), MAESTRO-NAFLD-Open-Label-Extension (MAESTRO-NAFLD-OLE)ACTIVE_NOT_RECRUITING2026-03PHASE32021-07-092026-04
NCT06049680Safety Study of SMOFlipid to Evaluate the Risk of Developing EFAD and/or PNAC in Pediatric and Adult PatientsRECRUITING2026-03PHASE42024-10-282026-09
NCT05125809Setrusumab vs Placebo for Osteogenesis ImperfectaACTIVE_NOT_RECRUITING2026-03PHASE2, PHASE32022-02-212027-04
NCT05117476A Study of CLN-619 Alone and in Combination With Pembrolizumab in Advanced Solid TumorsRECRUITING2026-03PHASE12021-10-292026-06
NCT03893955A Study to Determine the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of ABBV-927 With ABBV-368, Budigalimab (ABBV-181) and/or Chemotherapy in Participants With Locally Advanced or Metastatic Solid TumorsACTIVE_NOT_RECRUITING2026-03PHASE12019-05-212026-03
NCT02988960A Study of ABBV-927 and ABBV-181, an Immunotherapy, in Participants With Advanced Solid TumorsACTIVE_NOT_RECRUITING2026-03PHASE12017-02-222026-03
NCT06858696A Study to Investigate Pharmacokinetics (PK) and Safety of a Single Dose of Mavorixafor in Participants With Hepatic Impairment (HI) Compared to Matched Healthy Volunteers With Normal Hepatic FunctionRECRUITING2026-03PHASE12025-02-282026-04
NCT06052852Study of BDC-3042 as Single Agent and in Combination With Cemiplimab in Patients With Advanced MalignanciesACTIVE_NOT_RECRUITING2026-03PHASE12023-10-112028-03
NCT07024797Study to Assess the Adverse Events, Tolerability, and How Oral Doses of ABBV-932 Moves Through the Body in Healthy Adult Chinese ParticipantsRECRUITING2026-03PHASE12025-08-212026-03
NCT04561362Study BT8009-100 in Subjects With Nectin-4 Expressing Advanced MalignanciesRECRUITING2026-03PHASE1, PHASE22020-07-172026-12
NCT07165015A Study of Pharmacokinetics and Safety of LY3537031 in Participants With Normal Renal Function and Participants With Renal ImpairmentNOT_YET_RECRUITING2026-03PHASE12025-092026-03
NCT06374797A Study of Auxora in Patients With AKI and Injurious Lung "Crosstalk"RECRUITING2026-03PHASE22024-07-012026-03
NCT05016245MANDARIN (S6371)ACTIVE_NOT_RECRUITING2026-02-28PHASE32021-09-132026-10-30
NCT07063342A Study to Evaluate Novel KarX and KarT Prototypes Versus the KarXT and KarX-EC Reference Following Single Doses, and to Explore the Effect of Food After Multiple Doses of Selected Prototypes in Healthy Adult ParticipantsRECRUITING2026-02-28PHASE12025-06-272026-02-28
NCT05155605PATHFINDER 2: a Multi-Cancer Early Detection StudyACTIVE_NOT_RECRUITING2026-02-28NA2021-12-082028-04-30
NCT06799533A Study to Learn About the Study Medicine Called PF-08046031 in Advanced Melanoma and Other Solid TumorsACTIVE_NOT_RECRUITING2026-02-28PHASE12025-05-012026-02-28
NCT05132075Study of JDQ443 in Comparison With Docetaxel in Participants With Locally Advanced or Metastatic KRAS G12C Mutant Non-small Cell Lung CancerACTIVE_NOT_RECRUITING2026-02-28PHASE32022-06-152026-03-30
NCT06870487A Study to Learn About the Study Medicine Called PF-08046032 in People With Advanced CancersACTIVE_NOT_RECRUITING2026-02-27PHASE12025-05-082026-02-27
NCT04619420A Study of JNJ-63733657 in Participants With Early Alzheimer's DiseaseACTIVE_NOT_RECRUITING2026-02-27PHASE22021-01-062032-12-30
NCT04796337A Long-term Follow-up Study of Sotatercept for PAH Treatment (MK-7962-004/A011-12)ACTIVE_NOT_RECRUITING2026-02-27PHASE32021-05-122026-02-27
NCT06386419A Clinical Study to Evaluate the Safety and Effectiveness of Inclisiran Sodium in Indian Patients With Primary Hypercholesterolemia or Mixed DyslipidemiaACTIVE_NOT_RECRUITING2026-02-27PHASE42024-11-122026-02-27
NCT05660265A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of Oral GSK4172239D Compared With Placebo in Sickle Cell Disease Participants Aged 18 to 50 YearsRECRUITING2026-02-27PHASE12023-08-262026-02-27
NCT04023552Assessing the Impact of Lipoprotein (a) Lowering With Pelacarsen (TQJ230) on Major Cardiovascular Events in Patients With CVDACTIVE_NOT_RECRUITING2026-02-26PHASE32019-12-122026-02-26
NCT07071558Study to Evaluate the Safety and Immunogenicity of Investigational Vaccines Using the RSV (Respiratory Syncytial Virus) Monovalent Antigen in Healthy Participants 18 to 49 Years of AgeACTIVE_NOT_RECRUITING2026-02-26PHASE12025-07-142026-02-26
NCT05811351A Study to Evaluate Intravitreal JNJ-81201887 (AAVCAGsCD59) Compared to Sham Procedure for the Treatment of Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)ACTIVE_NOT_RECRUITING2026-02-26PHASE22023-03-062026-02-26
NCT05588843Dose-finding Study of SAR443122 in Adult Participants With Ulcerative ColitisRECRUITING2026-02-25PHASE22022-11-252026-12-16
NCT05688475A Rollover Study of CC-122ACTIVE_NOT_RECRUITING2026-02-25PHASE12023-04-112026-02-25
NCT06113445A Study to Evaluate Efficacy and Safety of Povorcitinib in Participants With Nonsegmental Vitiligo (STOP-V1)ACTIVE_NOT_RECRUITING2026-02-25PHASE32023-11-292027-02-24
NCT05592990A Study to Investigate the Safety, Tolerability and Preliminary Efficacy of NGI226 Microparticles in Patients With Achilles TendinopathyRECRUITING2026-02-24PHASE22023-06-142026-02-24
NCT05397223A Study of Modified mRNA Vaccines in Healthy AdultsACTIVE_NOT_RECRUITING2026-02-21PHASE12022-05-242026-02-21
NCT06221969A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Tirzepatide in People With Type 2 Diabetes Treated With Metformin With or Without an SGLT2 InhibitorACTIVE_NOT_RECRUITING2026-02-20PHASE32024-01-162026-04-03
NCT04624659A Study of Etavopivat in Adults and Adolescents With Sickle Cell Disease (HIBISCUS)ACTIVE_NOT_RECRUITING2026-02-20PHASE32021-01-292027-03-19
NCT05704049A Study to Investigate Subcutaneous Isatuximab in Combination With Carfilzomib and Dexamethasone in Adult Participants With Relapsed and/or Refractory Multiple MyelomaRECRUITING2026-02-20PHASE22023-04-052028-05-18
NCT06181240Modification of Coronary Calcium With Laser Based Intravascular Lithotripsy for Coronary Artery Disease (FRACTURE)RECRUITING2026-02-20NA2023-11-172028-03-20
NCT06137729A Study to Learn How the Study Medicine PF-07899895 Are Tolerated and Act in the Body of Healthy AdultsRECRUITING2026-02-19PHASE12023-11-172026-02-19
NCT06196879A Study to Investigate the Efficacy and Safety of Verekitug (UPB-101) in Adult Participants With Severe Asthma (VALIANT)ACTIVE_NOT_RECRUITING2026-02-19PHASE22024-02-272026-06-11
NCT05852938A Study of Zigakibart in Adults With IgA NephropathyACTIVE_NOT_RECRUITING2026-02-19PHASE32023-07-062028-06-07
NCT07069725The Phase 1, Open-label, PET Trial Designed to Investigate the Effect of AZD2389 on FAP Occupancy in the Liver in Participants With Advanced Liver Fibrosis.RECRUITING2026-02-19PHASE12025-05-262026-02-19
NCT06812078A Study of TAK-360 in Adults With Idiopathic HypersomniaRECRUITING2026-02-19PHASE22025-02-072026-02-19
NCT06672718A Study of SPY002-091 in Healthy VolunteersRECRUITING2026-02-18PHASE12024-11-262026-06-22
NCT06143046A Study of mRNA-1345 Vaccine Targeting Respiratory Syncytial Virus in Pregnant Women and in Infants Born to Vaccinated MothersACTIVE_NOT_RECRUITING2026-02-18PHASE22023-11-152026-02-18
NCT05831176A Study to Learn How Well Dupilumab Works in Adult and Adolescent Participants With Eosinophilic Gastritis With or Without Eosinophilic Duodenitis and the Side Effects it May HaveACTIVE_NOT_RECRUITING2026-02-18PHASE22023-05-032026-11-25
NCT07190430A Study to Learn If the Study Medicine Called PF-08049820 Changes How the Body Processes the Other Study Medicines Called Oral Contraceptives, Midazolam, and Dabigatran in Healthy Adult Female ParticipantsNOT_YET_RECRUITING2026-02-17PHASE12025-10-032026-02-17
NCT05703607A Study to Learn About a Modified RNA Vaccine Against Shingles in Healthy AdultsACTIVE_NOT_RECRUITING2026-02-17PHASE22023-01-252030-08-20
NCT06018558Study to Assess the Safety and Efficacy of OCU410 for Geographic AtrophyACTIVE_NOT_RECRUITING2026-02-17PHASE1, PHASE22023-02-232026-05-29
NCT04006808A Study to Test GlaxoSmithKline's (GSK) Candidate Vaccine-GSK1437173A for Prevention of Shingles in Children With Kidney TransplantRECRUITING2026-02-16PHASE1, PHASE22019-10-252027-03-31
NCT06531538A Study to Learn About How a New Pneumococcal Vaccine Works in ChildrenACTIVE_NOT_RECRUITING2026-02-16PHASE22024-07-302026-02-16
NCT04811560A Phase 1/2 Study of Bleximenib in Participants With Acute Leukemia (cAMeLot-1)RECRUITING2026-02-16PHASE1, PHASE22021-05-192028-05-26
NCT06454721A Study to Determine the Biodistribution, Safety, and Tolerability of a Microdose of Radiolabeled BIIB080 Co-administered With BIIB080 in Healthy AdultsRECRUITING2026-02-16PHASE12025-01-302026-07-30
NCT04898634A Study of JNJ-78278343, a T-Cell-Redirecting Agent Targeting Human Kallikrein 2 (KLK2), for Advanced Prostate CancerACTIVE_NOT_RECRUITING2026-02-13PHASE12021-07-132026-02-16
NCT07065331A Study of Inhaled AZD8630 in Adolescents With AsthmaRECRUITING2026-02-13PHASE12025-06-112026-02-13
NCT05572515A Study Comparing Teclistamab Monotherapy Versus Pomalidomide, Bortezomib, Dexamethasone (PVd) or Carfilzomib, Dexamethasone (Kd) in Participants With Relapsed or Refractory Multiple MyelomaRECRUITING2026-02-13PHASE32023-03-292031-08-31
NCT06299826A Phase IIb Study of AZD5462 in Patients With Chronic Heart FailureACTIVE_NOT_RECRUITING2026-02-12PHASE22024-06-042026-02-12
NCT05938270A Study to Investigate the Biological Effects of Saruparib (AZD5305), Darolutamide, and in Combination in Men With Newly Diagnosed Prostate Cancer.RECRUITING2026-02-11PHASE12023-09-212026-02-11
NCT04586231A Study of Belzutifan (MK-6482) in Combination With Lenvatinib Versus Cabozantinib for Treatment of Renal Cell Carcinoma (MK-6482-011)ACTIVE_NOT_RECRUITING2026-02-11PHASE32021-02-252027-02-11
NCT03767244A Study of Apalutamide in Participants With High-Risk, Localized or Locally Advanced Prostate Cancer Who Are Candidates for Radical ProstatectomyACTIVE_NOT_RECRUITING2026-02-10PHASE32019-06-112029-07-19
NCT05755035A Study About How TAK-881 is Processed by the Body and Side Effects in People With Primary Immunodeficiency DiseasesACTIVE_NOT_RECRUITING2026-02-10PHASE2, PHASE32023-10-242026-09-30
NCT06248619A Trial to Investigate Teprotumumab Subcutaneous Administration Compared With Placebo in Male and Female Adult Participants With Moderate-to-severe Active Thyroid Eye DiseaseACTIVE_NOT_RECRUITING2026-02-10PHASE32024-07-052026-09-29
NCT05325866A Study Evaluating Bemarituzumab in Solid Tumors With Fibroblast Growth Factor Receptor 2b (FGFR2b) OverexpressionACTIVE_NOT_RECRUITING2026-02-06PHASE1, PHASE22022-09-232026-02-06
NCT05455320A Study Comparing Talquetamab in Combination With Daratumumab or in Combination With Daratumumab and Pomalidomide Versus Daratumumab in Combination With Pomalidomide and Dexamethasone in Participants With Multiple Myeloma That Returns After Treatment or is Resistant to TreatmentACTIVE_NOT_RECRUITING2026-02-06PHASE32022-10-132029-06-30
NCT05739942Dose Finding Study of [177Lu]Lu-NeoB in Newly Diagnosed Glioblastoma and in Recurrent GlioblastomaRECRUITING2026-02-05PHASE12024-05-152031-08-28
NCT05938387Safety and Tolerability of CVGBM in Adults with Newly Diagnosed MGMT-Unmethylated Glioblastoma or AstrocytomaACTIVE_NOT_RECRUITING2026-02-04PHASE12023-06-012026-02-04
NCT05552976A Study to Evaluate Mezigdomide in Combination With Carfilzomib and Dexamethasone (MeziKD) Versus Carfilzomib and Dexamethasone (Kd) in Participants With Relapsed or Refractory Multiple Myeloma (SUCCESSOR-2)RECRUITING2026-02-04PHASE32023-01-102029-07-25
NCT04740476An Open-Label Extension Study of STK-001 for Patients With Dravet SyndromeENROLLING_BY_INVITATION2026-02-03PHASE22021-01-202027-03-03
NCT07019909A Study to Learn About How Safe and Effective is 20vPnC and 13vPnC Vaccines in Chinese AdultsACTIVE_NOT_RECRUITING2026-02-03PHASE12025-07-062026-02-03
NCT06290128A Study to Test the Effects and Safety of Riliprubart in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) for Which the Usual Treatments do Not WorkRECRUITING2026-02-03PHASE32024-07-122027-10-12
NCT06096337Pulsed Field Ablation (PFA) vs Anti-Arrhythmic Drug (AAD) Therapy as a First Line Treatment for Persistent Atrial FibrillationACTIVE_NOT_RECRUITING2026-02-03NA2023-12-282028-02-03
NCT06974084Investigating Measurable PRO Acuity Trial (IMPACT) is a Multi-Center Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy of Maraviroc and Atorvastatin to Improve Neurocognitive and Physical Function of Subjects With Long COVID-19/Post-Acute Sequelae of COVID-19 (PASC).NOT_YET_RECRUITING2026-02-01PHASE2, PHASE32025-09-012026-04
NCT02723994A Phase 2 Study of Ruxolitinib With Chemotherapy in Children With Acute Lymphoblastic LeukemiaACTIVE_NOT_RECRUITING2026-02-01PHASE22016-09-302026-02-01
NCT03564340Study of REGN4018 (Ubamatamab) Administered Alone or in Combination With Cemiplimab in Adult Patients With Recurrent Ovarian Cancer or Other Recurrent Mucin-16 Expressing (MUC16+) CancersRECRUITING2026-02-01PHASE1, PHASE22018-05-212027-01-31
NCT06137157Evaluation of Topical ATR12-351 in Adults With Netherton SyndromeRECRUITING2026-02-01PHASE12024-06-192026-04-01
NCT04762069A Study of Berubicin in Adult Subjects With Recurrent Glioblastoma MultiformeACTIVE_NOT_RECRUITING2026-02-01PHASE22021-05-182026-03-31
NCT04838769REZĹŞM vs. Dual Drug Therapy for Symptomatic Benign Prostatic Hyperplasia in Sexually Active MenACTIVE_NOT_RECRUITING2026-02NA2021-09-152027-03
NCT06859294A Study of LY3541860 in Adult Participants With Moderately to Severely Active Rheumatoid ArthritisRECRUITING2026-02PHASE22025-03-192026-09
NCT06109181Gene Therapy for ACM Due to a PKP2 Pathogenic VariantRECRUITING2026-02PHASE1, PHASE22024-02-292027-02
NCT06953934A Mass Balance Study of Oral [14C] ABBV-932 in Healthy Adult Male ParticipantsNOT_YET_RECRUITING2026-02PHASE12025-10-142026-02
NCT05540860A Study of EDG-5506 in Children With Duchenne Muscular Dystrophy (LYNX)ACTIVE_NOT_RECRUITING2026-02PHASE22022-10-242026-02
NCT05848258An Adaptive Phase 2a/2b Study of LY3871801 in Adult Participants With Rheumatoid ArthritisRECRUITING2026-02PHASE22023-05-232026-07
NCT05711940Efficacy, Safety, and Tolerability of Two Administrations of COMP360 in Participants With TRDRECRUITING2026-02PHASE32023-02-142026-12
NCT05703971Quaratusugene Ozeplasmid (Reqorsa) and Atezolizumab Maintenance Therapy in ES-SCLC PatientsRECRUITING2026-02PHASE1, PHASE22024-05-092027-08
NCT06547125A Study to Assess Adverse Events and Effectiveness of Intradermally Injected JUVÉDERM® VOLITE™ Gel Filler in Adult Participants For the Improvement of Skin QualityACTIVE_NOT_RECRUITING2026-02PHASE2, PHASE32024-07-182026-02
NCT05186974Study of Sacituzumab Govitecan Combinations in First-line Treatment of Participants With Advanced or Metastatic Non-Small-Cell Lung Cancer (NSCLC)ACTIVE_NOT_RECRUITING2026-02PHASE22022-05-302026-02
NCT03844048An Extension Study of Venetoclax for Subjects Who Have Completed a Prior Venetoclax Clinical TrialACTIVE_NOT_RECRUITING2026-02PHASE32019-09-062026-02
NCT05149755Evolut™ EXPAND TAVR II Pivotal TrialACTIVE_NOT_RECRUITING2026-02NA2022-04-272034-12
NCT06637072A Study to Assess Adults With CIDP Transitioning From IVIg to Efgartigimod PH20 SCRECRUITING2026-02PHASE42024-12-102026-02
NCT05201404Namodenoson in the Treatment of Advanced Hepatocellular Carcinoma in Patients With Child-Pugh Class B7 CirrhosisRECRUITING2026-02PHASE32023-03-152026-10
NCT06990399A Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-101 in Participants With Macular Edema Secondary to Inflammation (MESI) - PEAKRECRUITING2026-02PHASE32025-07-302027-07
NCT02682511Oral Ifetroban to Treat Diffuse Cutaneous Systemic Sclerosis (SSc) or SSc-associated Pulmonary Arterial HypertensionACTIVE_NOT_RECRUITING2026-02PHASE22017-012026-05
NCT02399124Post Marketing Surveillance for PROSENSE™ a Cryotherapy Treatment of Renal Cell CarcinomaACTIVE_NOT_RECRUITING2026-02NA2014-072026-02
NCT06830746ASCEND CSP IDE StudyRECRUITING2026-02NA2025-04-112028-05
NCT04721015Study of Intravenous (IV) ABBV-637 Alone or in Combination With IV Docetaxel/Osimertinib to Assess Adverse Events and Change in Disease Activity in Adult Participants With Relapsed/Refractory (R/R) Solid TumorsACTIVE_NOT_RECRUITING2026-02PHASE12021-02-232026-02
NCT05804435iNod™ Ultrasound-Guided Needle Biopsy System StudyWITHDRAWN2026-02NA2025-012027-02
NCT05433142Study of XmAb®819 in Subjects With Advanced Clear Cell Renal Cell CarcinomaRECRUITING2026-02PHASE12022-06-132027-11
NCT06525077Safety and Efficacy of FT218 in Idiopathic Hypersomnia (REVITALYZ)RECRUITING2026-02PHASE32024-08-012026-09
NCT05343481Efficacy of VTP-300 in Chronic Hepatitis B InfectionACTIVE_NOT_RECRUITING2026-02PHASE22022-09-212026-10
NCT05635643Study of CHS-114 in Participants With Advanced Solid TumorsRECRUITING2026-02PHASE12022-12-152026-02
NCT02625480Study Evaluating Brexucabtagene Autoleucel (KTE-X19) in Pediatric and Adolescent Participants With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia or Relapsed/Refractory B-Cell Non-Hodgkin LymphomaACTIVE_NOT_RECRUITING2026-02PHASE1, PHASE22016-02-012026-02
NCT06700538Study of ARO-INHBE in Adults With Obesity With and Without Diabetes MellitusRECRUITING2026-02PHASE1, PHASE22024-12-042026-02
NCT05566795DAY101 vs. Standard of Care Chemotherapy in Pediatric Participants With Low-Grade Glioma Requiring First-Line Systemic Therapy (LOGGIC/FIREFLY-2)RECRUITING2026-02PHASE32023-02-272030-03
NCT06058039Study to Assess the Effects of Oral NMRA-335140 in Participants With Major Depressive DisorderRECRUITING2026-02PHASE32023-12-212026-03
NCT06869018A Study of LY3549492 in Japanese Participants With Type 2 Diabetes Mellitus (T2D) and Healthy Japanese ParticipantsRECRUITING2026-02PHASE12025-05-072026-02
NCT05693142AFFINITY DUCHENNE: RGX-202 Gene Therapy in Participants With Duchenne Muscular Dystrophy (DMD)RECRUITING2026-02PHASE2, PHASE32023-01-042028-08
NCT05249101A Study of Ivaltinostat Plus Capecitabine or Capecitabine in Metastatic Pancreatic AdenocarcinomaRECRUITING2026-02PHASE1, PHASE22022-08-152026-06
NCT04262466Safety and Efficacy of IMC-F106C as a Single Agent and in Combination With Checkpoint InhibitorsRECRUITING2026-02PHASE1, PHASE22020-02-252026-08
NCT04036682A Phase 1/2 Trial of CLN-081 in Patients With Non-Small Cell Lung CancerACTIVE_NOT_RECRUITING2026-01-31PHASE1, PHASE22019-10-312026-03-31
NCT06046443A Study to Assess Efficacy and Safety of LB54640 in Patients With Hypothalamic ObesityACTIVE_NOT_RECRUITING2026-01-31PHASE22024-07-112026-01-31
NCT06241950A Gene Transfer Therapy Study to Evaluate the Safety and Efficacy of Delandistrogene Moxeparvovec (SRP-9001) Following Imlifidase Infusion in Participants With Duchenne Muscular Dystrophy (DMD) Determined to Have Pre-existing Antibodies to Recombinant Adeno-Associated Virus Serotype (rAAVrh74)ENROLLING_BY_INVITATION2026-01-31PHASE12024-01-292027-10-31
NCT04159103Open-Label Study of mRNA-3927 in Participants With Propionic AcidemiaRECRUITING2026-01-31PHASE1, PHASE22021-04-152026-01-31
NCT05686317ALT-FLOW II Trial of the Edwards APTURE Transcatheter Shunt SystemRECRUITING2026-01-31NA2023-04-012030-08-31
NCT05658237Clinical Study of PAL-222 Targeting Patients With Myopic Chorioretinal Atrophy (PAMyCA)ACTIVE_NOT_RECRUITING2026-01-31NA2023-02-172026-03-31
NCT06270836A Study to Evaluate the Efficacy and Safety of Tarcocimab Tedromer Compared With Sham Treatment in Participants With Diabetic Retinopathy (DR)ACTIVE_NOT_RECRUITING2026-01-31PHASE32024-05-012026-01-31
NCT03600883A Phase 1/2, Study Evaluating the Safety, Tolerability, PK, and Efficacy of Sotorasib (AMG 510) in Subjects With Solid Tumors With a Specific KRAS Mutation (CodeBreaK 100)ACTIVE_NOT_RECRUITING2026-01-31PHASE1, PHASE22018-08-272026-01-31
NCT05907954(Neo)Adjuvant IDE196 (Darovasertib) in Patients With Localized Ocular MelanomaRECRUITING2026-01-31PHASE22023-07-032029-01-31
NCT05469737A Study to Compare the Efficacy and Safety of Oral Azacitidine Plus Best Supportive Care (BSC) Versus Placebo Plus BSC in Participants With International Prognostic Scoring System Revised (IPSS-R) Low- or Intermediate-risk Myelodysplastic Syndrome (MDS)ACTIVE_NOT_RECRUITING2026-01-31PHASE2, PHASE32022-12-142026-07-29
NCT06805513Actual Use Trial of Tadalafil 5 mgRECRUITING2026-01-31PHASE32025-01-302026-02-28
NCT06772597A Single-center Study of Setmelanotide in Patients With Prader-Willi SyndromeRECRUITING2026-01-31PHASE22025-03-042026-01-31
NCT06067828A Study to Evaluate the Effect of Budesonide, Glycopyrronium, Formoterol Fumarate (BGF) Metered Dose Inhaler (MDI), Budesonide and Formoterol Fumarate (BFF) MDI and Placebo MDI on Exercise Parameters in Participants With Chronic Obstructive Pulmonary Disease (COPD).RECRUITING2026-01-30PHASE32023-10-242026-01-30
NCT06500793Single and Multi-Dose Study, Pharmacokinetics of Oxycodone and PF614 Co-Administered With Nafamostat (PF614-MPAR-102)RECRUITING2026-01-30PHASE12024-11-242026-03-27
NCT04471844Pivotal, Randomized, Open-label Study of Optune® (Tumor Treating Fields) Concomitant With RT & TMZ for the Treatment of Newly Diagnosed GBMACTIVE_NOT_RECRUITING2026-01-30NA2020-12-082026-01-30
NCT05660967Subcutaneous Epcoritamab With or Without Lenalidomide as First Line Therapy for Diffuse Large B-Cell LymphomaACTIVE_NOT_RECRUITING2026-01-30PHASE22023-03-062027-07-31
NCT03934372Safety and Efficacy of Ponatinib for Treatment of Pediatric Recurrent or Refractory Leukemias, Lymphomas or Solid TumorsRECRUITING2026-01-30PHASE1, PHASE22020-01-292026-01-30
NCT06941792Inclisiran Effectiveness in China: a Pragmatic Randomized TrialRECRUITING2026-01-30PHASE42025-06-172026-01-30
NCT05438043A Study of DaratumumabRECRUITING2026-01-30PHASE32022-12-152029-01-31
NCT05908734A Study of Combination Therapy With Amivantamab and Cetrelimab in Participants With Metastatic Non-small Cell Lung CancerACTIVE_NOT_RECRUITING2026-01-30PHASE1, PHASE22023-05-182026-09-26
NCT05111626Bemarituzumab Plus Chemotherapy and Nivolumab Versus Chemotherapy and Nivolumab for FGFR2b Overexpressed Untreated Advanced Gastric and Gastroesophageal Junction Cancer.ACTIVE_NOT_RECRUITING2026-01-29PHASE32022-03-142027-01-29
NCT07128615A Phase I/II Study on Safety AND Immunogenicity of AZD4117 and AZD5315 Vaccines (PANDA)RECRUITING2026-01-29PHASE1, PHASE22025-09-042027-01-07
NCT05251259Study to Assess the Efficacy and Safety of Atuliflapon in Moderate-to-Severe Uncontrolled AsthmaACTIVE_NOT_RECRUITING2026-01-29PHASE22022-01-272026-01-29
NCT06593600Study of Natriuretic Peptide Receptor 1 (NPR1) Antagonist in Adult Patients With Postural Orthostatic Tachycardia Syndrome (POTS)RECRUITING2026-01-28PHASE22024-11-132026-04-21
NCT07135986Immunogenicity and Safety Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Healthy Children and Adolescents in ChinaNOT_YET_RECRUITING2026-01-28PHASE32025-09-262026-06-29
NCT04480853Safety and Efficacy Study of Fingolimod in Taiwanese Adults (≥ 20years) With Relapsing Remitting Multiple SclerosisRECRUITING2026-01-27PHASE42020-10-122026-01-27
NCT05583344Phase 2b Study of GSK4532990 in Adults With NASHACTIVE_NOT_RECRUITING2026-01-26PHASE22023-01-022027-04-05
NCT03924856Perioperative Pembrolizumab (MK-3475) Plus Neoadjuvant Chemotherapy Versus Perioperative Placebo Plus Neoadjuvant Chemotherapy for Cisplatin-eligible Muscle-invasive Bladder Cancer (MIBC) (MK-3475-866/KEYNOTE-866)ACTIVE_NOT_RECRUITING2026-01-26PHASE32019-06-132026-09-01
NCT06696170Evaluation of the CellFX® Nano-Pulsed Field Ablation (PFA) 360 Catheter Endocardial Ablation System for the Treatment of Atrial FibrillationRECRUITING2026-01-25NA2024-07-252026-04-25
NCT06699680Phase 1 Study of PRX019 in Healthy Adult VolunteersRECRUITING2026-01-23PHASE12024-11-082026-01-23
NCT06120504A Safety Study of PF-08046045/SGN-35T in Adults With Advanced CancersACTIVE_NOT_RECRUITING2026-01-21PHASE12024-02-292026-01-21
NCT05462873A Study to Investigate the Safety and Tolerability of Intravenous QEQ278 in Patients With Advanced Solid TumorsACTIVE_NOT_RECRUITING2026-01-20PHASE12023-04-042026-01-20
NCT05166889Efficacy and Safety of Tozorakimab in Symptomatic Chronic Obstructive Pulmonary Disease With a History of ExacerbationsACTIVE_NOT_RECRUITING2026-01-19PHASE32022-01-032026-03-23
NCT04530123Dose-Ranging Study of the Efficacy and Safety of TAK-101 for Prevention of Gluten-Specific T Cell Activation in Participants With Celiac Disease on a Gluten-Free DietACTIVE_NOT_RECRUITING2026-01-19PHASE22022-06-232026-01-19
NCT06639997Safety and Tolerability of AZD5148 in Japanese ParticipantsACTIVE_NOT_RECRUITING2026-01-19PHASE12024-10-312026-01-19
NCT04193215V114 and Acute Otitis Media (V114-032/PNEU-ERA)ACTIVE_NOT_RECRUITING2026-01-19PHASE32020-09-122026-01-19
NCT05158387Efficacy and Safety of Tozorakimab in Symptomatic Chronic Obstructive Pulmonary Disease With a History of Exacerbations.ACTIVE_NOT_RECRUITING2026-01-19PHASE32022-02-072026-03-23
NCT05092347A Study to Learn How Safe and Tolerable Vonsetamig is in Adult Patients With Chronic Kidney Disease (CKD) Who Need Kidney Transplantation and Are Highly Sensitized to Human Leukocyte Antigen (HLA)RECRUITING2026-01-17PHASE1, PHASE22022-08-022026-12-12